{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:53:33Z","timestamp":1791244413132,"version":"4.1.0"},"reference-count":477,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Key Laboratory of Artificial Organs and Computational Medicine of Zhejiang Province"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glutamine is the most abundant free amino acid in the body. It plays a central role in cellular metabolism, connecting synthetic and catabolic pathways, and maintaining life activities under physiological and pathological conditions. This review systematically explores the dual role of glutamine metabolism in health and disease. Glutamine is not only the main energy and nitrogen source for rapidly proliferating cells, such as immune cells, intestinal epithelial cells, and cancer cells but also participates in several key biological processes, such as nucleotide synthesis, REDOX balance, and immune regulation. Glutamine metabolism is often abnormally activated or disrupted in disease states, such as \u201cglutamine addiction\u201d in cancer and excitotoxicity and mitochondrial dysfunction in neurodegenerative diseases. Disorders of glutamine metabolism are also present in metabolic diseases (such as diabetes and MAFLD) and cardiovascular diseases. In addition, gut microbes regulate host glutamine metabolism through metabolites and signaling pathways, further affecting the disease process. Therapeutic strategies to target glutamine metabolism include inhibition of key enzymes or transporters, as well as exogenous glutamine supplementation. However, the effects of these strategies are context-dependent and need to be applied individually according to the specific pathological status of patients. Future research should focus on tissue-specific metabolic profiling, integrated multiomics analysis, and the development of combined treatment strategies to fully realize the potential of glutamine metabolism in disease treatment.<\/jats:p>","DOI":"10.1038\/s41392-026-02981-1","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:02:49Z","timestamp":1791241369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glutamine metabolism in health and disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Junsheng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hainv","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"2981_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/ajcn\/79.2.185","volume":"79","author":"MCG van de Poll","year":"2004","unstructured":"van de Poll, M. C. G. et al. Renal metabolism of amino acids: its role in interorgan amino acid exchange. Am. J. Clin. Nutr. 79, 185\u2013197 (2004).","journal-title":"Am. J. Clin. Nutr."},{"key":"2981_CR2","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1007\/s00726-014-1773-4","volume":"47","author":"B Wang","year":"2014","unstructured":"Wang, B. et al. Glutamine and intestinal barrier function. Amino Acids 47, 2143\u20132154 (2014).","journal-title":"Amino Acids"},{"key":"2981_CR3","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s12276-020-00504-8","volume":"52","author":"HC Yoo","year":"2020","unstructured":"Yoo, H. C., Yu, Y. C., Sung, Y. & Han, J. M. Glutamine reliance in cell metabolism. Exp. Mol. Med. 52, 1496\u20131516 (2020).","journal-title":"Exp. Mol. Med."},{"key":"2981_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.aninu.2015.08.008","volume":"1","author":"M Watford","year":"2015","unstructured":"Watford, M. Glutamine and glutamate: nonessential or essential amino acids?. Anim. Nutr. 1, 119\u2013122 (2015).","journal-title":"Anim. Nutr."},{"key":"2981_CR5","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3390\/nu10111564","volume":"10","author":"V Cruzat","year":"2018","unstructured":"Cruzat, V. et al. Glutamine: metabolism and immune function, supplementation and clinical translation. Nutrients 10, 1564 (2018).","journal-title":"Nutrients"},{"key":"2981_CR6","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3390\/nu11040863","volume":"11","author":"AY Coqueiro","year":"2019","unstructured":"Coqueiro, A. Y., Rogero, M. M. & Tirapegui, J. Glutamine as an anti-fatigue amino acid in sports nutrition. Nutrients 11, 863 (2019).","journal-title":"Nutrients"},{"key":"2981_CR7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/mrd.23570","volume":"90","author":"GA Johnson","year":"2022","unstructured":"Johnson, G. A. et al. Metabolic pathways utilized by the porcine conceptus, uterus, and placenta. Mol. Reprod. Dev. 90, 673\u2013683 (2022).","journal-title":"Mol. Reprod. Dev."},{"key":"2981_CR8","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1530\/ERC-15-0192","volume":"22","author":"L Yuan","year":"2015","unstructured":"Yuan, L. et al. Glutamine promotes ovarian cancer cell proliferation through the mTOR\/S6 pathway. Endocr. Relat. Cancer 22, 577\u2013591 (2015).","journal-title":"Endocr. Relat. Cancer"},{"key":"2981_CR9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cmet.2019.11.019","volume":"31","author":"P Petrus","year":"2020","unstructured":"Petrus, P. et al. Glutamine links obesity to inflammation in human white adipose tissue. Cell Metab. 31, 375\u2013390.e311 (2020).","journal-title":"Cell Metab."},{"key":"2981_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24301-7","volume":"12","author":"X Liu","year":"2021","unstructured":"Liu, X. et al. Hexosamine biosynthetic pathway and O-GlcNAc-processing enzymes regulate daily rhythms in protein O-GlcNAcylation. Nat. Commun. 12, 4173 (2021).","journal-title":"Nat. Commun."},{"key":"2981_CR11","doi-asserted-by":"publisher","first-page":"130250","DOI":"10.1016\/j.bbagen.2022.130250","volume":"1867","author":"N Itano","year":"2023","unstructured":"Itano, N. & Iwamoto, S. Dysregulation of hexosamine biosynthetic pathway wiring metabolic signaling circuits in cancer. Biochim. Biophys. Acta (BBA) - Gen. Subj. 1867, 130250 (2023).","journal-title":"Biochim. Biophys. Acta (BBA) - Gen. Subj."},{"key":"2981_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","volume":"14","author":"UE Martinez-Outschoorn","year":"2016","unstructured":"Martinez-Outschoorn, U. E. et al. Cancer metabolism: a therapeutic perspective. Nat. Rev. Clin. Oncol. 14, 11\u201331 (2016).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2981_CR13","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1016\/j.molcel.2021.06.021","volume":"81","author":"JS Brunner","year":"2021","unstructured":"Brunner, J. S. & Finley, L. W. S. SnapShot: cancer metabolism. Mol. Cell. 81, 3878\u20133878.e3871 (2021).","journal-title":"Mol. Cell."},{"key":"2981_CR14","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.3390\/nu11092092","volume":"11","author":"W Durante","year":"2019","unstructured":"Durante, W. The emerging role of l-glutamine in cardiovascular health and disease. Nutrients 11, 2092 (2019).","journal-title":"Nutrients"},{"key":"2981_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pnmrs.2024.05.003","volume":"144-145","author":"K Dos Santos","year":"2024","unstructured":"Dos Santos, K., Bertho, G., Baudin, M. & Giraud, N. Glutamine: a key player in human metabolism as revealed by hyperpolarized magnetic resonance. Prog. Nucl. Magn. Reson. Spectrosc. 144-145, 15\u201339 (2024).","journal-title":"Prog. Nucl. Magn. Reson. Spectrosc."},{"key":"2981_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70120","volume":"6","author":"MA Kumar","year":"2025","unstructured":"Kumar, M. A. et al. Glutamine metabolism: molecular regulation, biological functions, and diseases. MedComm. 6, e70120 (2025).","journal-title":"MedComm."},{"key":"2981_CR17","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3389\/fimmu.2020.01517","volume":"11","author":"RA Brown","year":"2020","unstructured":"Brown, R. A. & Byersdorfer, C. A. Metabolic pathways in alloreactive T cells. Front. Immunol. 11, 1517 (2020).","journal-title":"Front. Immunol."},{"key":"2981_CR18","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1182\/blood.2019001034","volume":"134","author":"Y Tabe","year":"2019","unstructured":"Tabe, Y., Lorenzi, P. L. & Konopleva, M. Amino acid metabolism in hematologic malignancies and the era of targeted therapy. Blood 134, 1014\u20131023 (2019).","journal-title":"Blood"},{"key":"2981_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/mc.23349","volume":"61","author":"CS Wilder","year":"2021","unstructured":"Wilder, C. S., Chen, Z. & DiGiovanni, J. Pharmacologic approaches to amino acid depletion for cancer therapy. Mol. Carcinog. 61, 127\u2013152 (2021).","journal-title":"Mol. Carcinog."},{"key":"2981_CR20","doi-asserted-by":"publisher","first-page":"1345522","DOI":"10.3389\/fphar.2024.1345522","volume":"15","author":"Y Fan","year":"2024","unstructured":"Fan, Y. et al. Exploiting the Achilles\u2019 heel of cancer: disrupting glutamine metabolism for effective cancer treatment. Front. Pharmacol. 15, 1345522 (2024).","journal-title":"Front. Pharmacol."},{"key":"2981_CR21","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","volume":"55","author":"J Jin","year":"2023","unstructured":"Jin, J., Byun, J.-K., Choi, Y.-K. & Park, K.-G. Targeting glutamine metabolism as a therapeutic strategy for cancer. Exp. Mol. Med. 55, 706\u2013715 (2023).","journal-title":"Exp. Mol. Med."},{"key":"2981_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.molmed.2019.11.004","volume":"26","author":"ZE Stine","year":"2020","unstructured":"Stine, Z. E. & Dang, C. V. Glutamine skipping the Q into mitochondria. Trends Mol. Med. 26, 6\u20137 (2020).","journal-title":"Trends Mol. Med."},{"key":"2981_CR23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nrc.2016.71","volume":"16","author":"BJ Altman","year":"2016","unstructured":"Altman, B. J., Stine, Z. E. & Dang, C. V. From Krebs to clinic: glutamine metabolism to cancer therapy. Nat. Rev. Cancer. 16, 619\u2013634 (2016).","journal-title":"Nat. Rev. Cancer."},{"key":"2981_CR24","doi-asserted-by":"publisher","first-page":"e01179","DOI":"10.1128\/mBio.01179-17","volume":"8","author":"Y Zhu","year":"2017","unstructured":"Zhu, Y. et al. A critical role of glutamine and asparagine \u03b3-nitrogen in nucleotide biosynthesis in cancer cells hijacked by an oncogenic virus. mBio 8, e01179\u201301117 (2017).","journal-title":"mBio"},{"key":"2981_CR25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cmet.2019.11.020","volume":"31","author":"HC Yoo","year":"2020","unstructured":"Yoo, H. C. et al. A variant of SLC1A5 is a mitochondrial glutamine transporter for metabolic reprogramming in cancer cells. Cell Metab. 31, 267\u2013283.e212 (2020).","journal-title":"Cell Metab."},{"key":"2981_CR26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.molcel.2025.12.001","volume":"86","author":"L Zhu","year":"2026","unstructured":"Zhu, L. et al. Mitochondrial glutamine import sustains electron transport chain integrity independently of glutaminolysis in cancer. Mol. Cell 86, 150\u2013165.e159 (2026).","journal-title":"Mol. Cell"},{"key":"2981_CR27","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1016\/j.devcel.2024.07.015","volume":"59","author":"I Soro-Arn\u00e1iz","year":"2024","unstructured":"Soro-Arn\u00e1iz, I. et al. GLUD1 determines murine muscle stem cell fate by controlling mitochondrial glutamate levels. Dev. Cell. 59, 2850\u20132865.e2858 (2024).","journal-title":"Dev. Cell."},{"key":"2981_CR28","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cmet.2020.08.011","volume":"32","author":"CS Kim","year":"2020","unstructured":"Kim, C. S. et al. Glutamine metabolism controls stem cell fate reversibility and long-term maintenance in the hair follicle. Cell Metab. 32, 629\u2013642.e628 (2020).","journal-title":"Cell Metab."},{"key":"2981_CR29","doi-asserted-by":"publisher","first-page":"116181","DOI":"10.1016\/j.bcp.2024.116181","volume":"228","author":"LH Lash","year":"2024","unstructured":"Lash, L. H. Renal glutathione: dual roles as antioxidant protector and bioactivation promoter. Biochem. Pharmacol. 228, 116181 (2024).","journal-title":"Biochem. Pharmacol."},{"key":"2981_CR30","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/s41556-024-01503-x","volume":"26","author":"H Zhang","year":"2024","unstructured":"Zhang, H. et al. Ammonia-induced lysosomal and mitochondrial damage causes cell death of effector CD8+ T cells. Nat. Cell Biol. 26, 1892\u20131902 (2024).","journal-title":"Nat. Cell Biol."},{"key":"2981_CR31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41590-022-01365-1","volume":"24","author":"K Tang","year":"2022","unstructured":"Tang, K. et al. Ammonia detoxification promotes CD8+ T cell memory development by urea and citrulline cycles. Nat. Immunol. 24, 162\u2013173 (2022).","journal-title":"Nat. Immunol."},{"key":"2981_CR32","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1016\/j.celrep.2019.07.098","volume":"28","author":"SC Tompkins","year":"2019","unstructured":"Tompkins, S. C. et al. Disrupting mitochondrial pyruvate uptake directs glutamine into the TCA cycle away from glutathione synthesis and impairs hepatocellular tumorigenesis. Cell Rep. 28, 2608\u20132619.e2606 (2019).","journal-title":"Cell Rep."},{"key":"2981_CR33","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.bbagen.2016.01.021","volume":"1860","author":"DR Sappington","year":"2016","unstructured":"Sappington, D. R. et al. Glutamine drives glutathione synthesis and contributes to radiation sensitivity of A549 and H460 lung cancer cell lines. Biochim. Biophys. Acta (BBA) Gen. Subj. 1860, 836\u2013843 (2016).","journal-title":"Biochim. Biophys. Acta (BBA) Gen. Subj."},{"key":"2981_CR34","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.tibs.2018.05.003","volume":"43","author":"P Kandasamy","year":"2018","unstructured":"Kandasamy, P., Gyimesi, G., Kanai, Y. & Hediger, M. A. Amino acid transporters revisited: new views in health and disease. Trends Biochem. Sci. 43, 752\u2013789 (2018).","journal-title":"Trends Biochem. Sci."},{"key":"2981_CR35","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3109\/02713680903461489","volume":"35","author":"MP Langford","year":"2010","unstructured":"Langford, M. P. et al. Glutamate, excitatory amino acid transporters, Xc\u2212antiporter, glutamine synthetase, and \u03b3-glutamyltranspeptidase in human corneal epithelium. Curr. Eye Res. 35, 202\u2013211 (2010).","journal-title":"Curr. Eye Res."},{"key":"2981_CR36","doi-asserted-by":"crossref","unstructured":"Singh, S., Arthur, S. & Sundaram, U. In Comprehensive Physiology Vol. 10 (ed Terjung R.) 673\u2013686 (Wiley, 2020).","DOI":"10.1002\/j.2040-4603.2020.tb00119.x"},{"key":"2981_CR37","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1126\/science.1259472","volume":"347","author":"JL Jewell","year":"2015","unstructured":"Jewell, J. L. et al. Differential regulation of mTORC1 by leucine and glutamine. Science 347, 194\u2013198 (2015).","journal-title":"Science"},{"key":"2981_CR38","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41392-026-02576-w","volume":"11","author":"H Chen","year":"2026","unstructured":"Chen, H. et al. Hyperglutaminolysis drives senescence and aging through arginine-mTORC1 axis activation. Signal Transduct. Target. Ther. 11, 64 (2026).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2981_CR39","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1038\/s44318-025-00505-1","volume":"44","author":"G Figlia","year":"2025","unstructured":"Figlia, G. et al. mTORC1 senses glutamine and other amino acids through GCN2. EMBO J. 44, 4825\u20134866 (2025).","journal-title":"EMBO J."},{"key":"2981_CR40","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41422-024-00985-6","volume":"34","author":"M Li","year":"2024","unstructured":"Li, M. et al. AMPK targets PDZD8 to trigger carbon source shift from glucose to glutamine. Cell Res. 34, 683\u2013706 (2024).","journal-title":"Cell Res."},{"key":"2981_CR41","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1126\/science.abb5916","volume":"371","author":"Y Johmura","year":"2021","unstructured":"Johmura, Y. et al. Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders. Science 371, 265\u2013270 (2021).","journal-title":"Science"},{"key":"2981_CR42","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.cmet.2019.01.002","volume":"29","author":"AO Adebayo Michael","year":"2019","unstructured":"Adebayo Michael, A. O. et al. Inhibiting glutamine-dependent mTORC1 activation ameliorates liver cancers driven by \u03b2-catenin mutations. Cell Metab. 29, 1135\u20131150.e1136 (2019).","journal-title":"Cell Metab."},{"key":"2981_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25079-4","volume":"12","author":"C Bodineau","year":"2021","unstructured":"Bodineau, C. et al. Two parallel pathways connect glutamine metabolism and mTORC1 activity to regulate glutamoptosis. Nat. Commun. 12, 4814 (2021).","journal-title":"Nat. Commun."},{"key":"2981_CR44","doi-asserted-by":"publisher","first-page":"100096","DOI":"10.1016\/j.mocell.2024.100096","volume":"47","author":"M Kim","year":"2024","unstructured":"Kim, M., Hwang, S. & Jeong, S. M. Targeting cellular adaptive responses to glutaminolysis perturbation for cancer therapy. Mol. Cells 47, 100096 (2024).","journal-title":"Mol. Cells"},{"key":"2981_CR45","doi-asserted-by":"publisher","DOI":"10.1172\/JCI161408","volume":"132","author":"W Dai","year":"2022","unstructured":"Dai, W. et al. Glutamine synthetase limits \u03b2-catenin\u2013mutated liver cancer growth by maintaining nitrogen homeostasis and suppressing mTORC1. J. Clin. Investig. 132, e161408 (2022).","journal-title":"J. Clin. Investig."},{"key":"2981_CR46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2003014118","volume":"118","author":"P-Y Tsai","year":"2021","unstructured":"Tsai, P.-Y. et al. Adaptation of pancreatic cancer cells to nutrient deprivation is reversible and requires glutamine synthetase stabilization by mTORC1. Proc. Natl. Acad. Sci. 118, e2003014118 (2021).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"2981_CR47","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.molcel.2016.02.032","volume":"61","author":"T Van Nguyen","year":"2016","unstructured":"Van Nguyen, T. et al. Glutamine triggers acetylation-dependent degradation of glutamine synthetase via the thalidomide receptor cereblon. Mol. Cell. 61, 809\u2013820 (2016).","journal-title":"Mol. Cell."},{"key":"2981_CR48","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/procel\/pwaf112","volume":"17","author":"P Gong","year":"2026","unstructured":"Gong, P. et al. Glutamine synthetase sustains cortical circuit development via mTOR-mediated astrocyte maturation. Protein Cell 17, 573\u2013577 (2026).","journal-title":"Protein Cell"},{"key":"2981_CR49","doi-asserted-by":"publisher","first-page":"G943","DOI":"10.1152\/ajpgi.1997.272.5.G943","volume":"272","author":"JM Rhoads","year":"1997","unstructured":"Rhoads, J. M. et al. L-glutamine stimulates intestinal cell proliferation and activates mitogen-activated protein kinases. Am. J. Physiol. Gastrointest. Liver Physiol. 272, G943\u2013G953 (1997).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2981_CR50","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/all.15121","volume":"77","author":"JM Kim","year":"2021","unstructured":"Kim, J. M. et al. Glutamine deficiency shifts the asthmatic state toward neutrophilic airway inflammation. Allergy 77, 1180\u20131191 (2021).","journal-title":"Allergy"},{"key":"2981_CR51","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/iej.12303","volume":"48","author":"DS Kim","year":"2014","unstructured":"Kim, D. S. et al. Anti-inflammatory effects of glutamine on LPS-stimulated human dental pulp cells correlate with activation of MKP-1 and attenuation of the MAPK and NF-\u03baB pathways. Int. Endod. J. 48, 220\u2013228 (2014).","journal-title":"Int. Endod. J."},{"key":"2981_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49256-3","volume":"15","author":"WY Wani","year":"2024","unstructured":"Wani, W. Y., Zunke, F., Belur, N. R. & Mazzulli, J. R. The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson\u2019s disease patient iPSC derived midbrain neurons. Nat. Commun. 15, 5206 (2024).","journal-title":"Nat. Commun."},{"key":"2981_CR53","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.stemcr.2023.05.012","volume":"18","author":"J Tian","year":"2023","unstructured":"Tian, J. et al. Glutamine boosts intestinal stem cell-mediated small intestinal epithelial development during early weaning: Involvement of WNT signaling. Stem Cell Rep. 18, 1451\u20131467 (2023).","journal-title":"Stem Cell Rep."},{"key":"2981_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110409","volume":"38","author":"AG Cicatiello","year":"2022","unstructured":"Cicatiello, A. G. et al. Thyroid hormone regulates glutamine metabolism and anaplerotic fluxes by inducing mitochondrial glutamate aminotransferase GPT2. Cell Rep. 38, 110409 (2022).","journal-title":"Cell Rep."},{"key":"2981_CR55","doi-asserted-by":"publisher","first-page":"E323","DOI":"10.1152\/ajpendo.2000.279.2.E323","volume":"279","author":"G Biolo","year":"2000","unstructured":"Biolo, G. et al. Growth hormone decreases muscle glutamine production and stimulates protein synthesis in hypercatabolic patients. Am. J. Physiol. Endocrinol. Metab. 279, E323\u2013E332 (2000).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2981_CR56","doi-asserted-by":"publisher","first-page":"624","DOI":"10.2337\/db20-0814","volume":"71","author":"L Dollet","year":"2022","unstructured":"Dollet, L. et al. Glutamine regulates skeletal muscle immunometabolism in type 2 diabetes. Diabetes 71, 624\u2013636 (2022).","journal-title":"Diabetes"},{"key":"2981_CR57","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccr.2013.08.020","volume":"24","author":"LuikaA Timmerman","year":"2013","unstructured":"Timmerman, L. uikaA. et al. Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target. Cancer Cell. 24, 450\u2013465 (2013).","journal-title":"Cancer Cell."},{"key":"2981_CR58","doi-asserted-by":"publisher","DOI":"10.1126\/science.adh9215","volume":"386","author":"J Lyu","year":"2024","unstructured":"Lyu, J. et al. A glutamine metabolic switch supports erythropoiesis. Science 386, eadh9215 (2024).","journal-title":"Science"},{"key":"2981_CR59","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1016\/j.cmet.2025.10.010","volume":"37","author":"L Guo","year":"2025","unstructured":"Guo, L. et al. Intestinal clock shapes sleep-wake cycle via sustaining glutamine homeostasis. Cell Metab. 37, 2423\u20132437.e2426 (2025).","journal-title":"Cell Metab."},{"key":"2981_CR60","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41586-020-2857-9","volume":"587","author":"M Shang","year":"2020","unstructured":"Shang, M. et al. Macrophage-derived glutamine boosts satellite cells and muscle regeneration. Nature 587, 626\u2013631 (2020).","journal-title":"Nature"},{"key":"2981_CR61","first-page":"144","volume":"17","author":"D H\u00e4ussinger","year":"1987","unstructured":"H\u00e4ussinger, D. Hepatic glutamine metabolism. Beitr. Infusionther. Klin. Ernahr. 17, 144\u2013157 (1987).","journal-title":"Beitr. Infusionther. Klin. Ernahr."},{"key":"2981_CR62","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/jimd.12061","volume":"42","author":"LR Soria","year":"2019","unstructured":"Soria, L. R. & Brunetti-Pierri, N. Ammonia and autophagy: an emerging relationship with implications for disorders with hyperammonemia. J. Inherit. Metab. Dis. 42, 1097\u20131104 (2019).","journal-title":"J. Inherit. Metab. Dis."},{"key":"2981_CR63","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1111\/jgh.16603","volume":"39","author":"B Njei","year":"2024","unstructured":"Njei, B. et al. Role of ammonia and glutamine in the pathogenesis and progression of metabolic dysfunction-associated steatotic liver disease: a systematic review. J. Gastroenterol. Hepatol. 39, 1788\u20131808 (2024).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"2981_CR64","doi-asserted-by":"publisher","first-page":"104809","DOI":"10.1016\/j.neuint.2020.104809","volume":"140","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y., Eid, T., Hassel, B. & Danbolt, N. C. Novel aspects of glutamine synthetase in ammonia homeostasis. Neurochem. Int. 140, 104809 (2020).","journal-title":"Neurochem. Int."},{"key":"2981_CR65","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/hep.28852","volume":"65","author":"TBM Hakvoort","year":"2017","unstructured":"Hakvoort, T. B. M. et al. Pivotal role of glutamine synthetase in ammonia detoxification. Hepatology 65, 281\u2013293 (2017).","journal-title":"Hepatology"},{"key":"2981_CR66","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1515\/hsz-2021-0166","volume":"402","author":"B Frieg","year":"2021","unstructured":"Frieg, B., G\u00f6rg, B., Gohlke, H. & H\u00e4ussinger, D. Glutamine synthetase as a central element in hepatic glutamine and ammonia metabolism: novel aspects. Biol. Chem. 402, 1063\u20131072 (2021).","journal-title":"Biol. Chem."},{"key":"2981_CR67","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/jimd.12070","volume":"42","author":"LR Soria","year":"2019","unstructured":"Soria, L. R. et al. Hepatic glutamine synthetase augmentation enhances ammonia detoxification. J. Inherit. Metab. Dis. 42, 1128\u20131135 (2019).","journal-title":"J. Inherit. Metab. Dis."},{"key":"2981_CR68","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1089\/nat.2020.0886","volume":"30","author":"M Khoshnejad","year":"2020","unstructured":"Khoshnejad, M. et al. DNA-encoded glutamine synthetase enzyme as ammonia-lowering therapeutic for hyperammonemia. Nucleic Acid Ther. 30, 379\u2013391 (2020).","journal-title":"Nucleic Acid Ther."},{"key":"2981_CR69","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0197-0186(02)00033-5","volume":"41","author":"I Su\u00e1rez","year":"2002","unstructured":"Su\u00e1rez, I., Bodega, G. & Fern\u00e1ndez, B. Glutamine synthetase in brain: effect of ammonia. Neurochem. Int. 41, 123\u2013142 (2002).","journal-title":"Neurochem. Int."},{"key":"2981_CR70","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1038\/s42003-025-09191-5","volume":"8","author":"Y Nasu","year":"2025","unstructured":"Nasu, Y. et al. Ammonia reduces glutamine synthetase expression in astrocytes via activation of Hippo-YAP signaling pathways. Commun. Biol. 8, 1810 (2025).","journal-title":"Commun. Biol."},{"key":"2981_CR71","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/s41589-022-01154-9","volume":"19","author":"VH Villar","year":"2022","unstructured":"Villar, V. H. et al. Hepatic glutamine synthetase controls N5-methylglutamine in homeostasis and cancer. Nat. Chem. Biol. 19, 292\u2013300 (2022).","journal-title":"Nat. Chem. Biol."},{"key":"2981_CR72","doi-asserted-by":"publisher","first-page":"F1229","DOI":"10.1152\/ajprenal.00547.2015","volume":"310","author":"H-W Lee","year":"2016","unstructured":"Lee, H.-W. et al. Proximal tubule-specific glutamine synthetase deletion alters basal and acidosis-stimulated ammonia metabolism. Am. J. Physiol. Renal Physiol. 310, F1229\u2013F1242 (2016).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2981_CR73","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/MNH.0000000000000255","volume":"25","author":"ID Weiner","year":"2016","unstructured":"Weiner, I. D. & Verlander, J. W. Recent advances in understanding renal ammonia metabolism and transport. Curr. Opin. Nephrol. Hypertens. 25, 436\u2013443 (2016).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"2981_CR74","doi-asserted-by":"publisher","first-page":"F208","DOI":"10.1152\/ajprenal.00358.2021","volume":"322","author":"H-W Lee","year":"2022","unstructured":"Lee, H.-W. et al. Acid-base effects of combined renal deletion of NBCe1-A and NBCe1-B. Am. J. Physiol. Renal Physiol. 322, F208\u2013F224 (2022).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2981_CR75","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/jcbfm.2013.218","volume":"34","author":"AW Fries","year":"2013","unstructured":"Fries, A. W. et al. Effect of glutamine synthetase inhibition on brain and interorgan ammonia metabolism in bile duct ligated rats. J. Cereb. Blood Flow Metab. 34, 460\u2013466 (2013).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"2981_CR76","doi-asserted-by":"publisher","first-page":"519","DOI":"10.5603\/pjnns.99826","volume":"58","author":"W El-Sayed","year":"2024","unstructured":"El-Sayed, W. et al. Association of glutamine synthetase polymorphisms rs2296521, rs10911021 and rs12136955 with plasma ammonia concentration in valproic acid-treated Egyptian epilepsy patients. Neurol. Neurochir. Pol. 58, 519\u2013530 (2024).","journal-title":"Neurol. Neurochir. Pol."},{"key":"2981_CR77","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.abb.2013.04.009","volume":"536","author":"J H\u00e4berle","year":"2013","unstructured":"H\u00e4berle, J. Clinical and biochemical aspects of primary and secondary hyperammonemic disorders. Arch. Biochem. Biophys. 536, 101\u2013108 (2013).","journal-title":"Arch. Biochem. Biophys."},{"key":"2981_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-02018-6","volume":"23","author":"D Nan","year":"2025","unstructured":"Nan, D. et al. Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets. Cell Commun. Signal. 23, 45 (2025).","journal-title":"Cell Commun. Signal."},{"key":"2981_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01449-x","volume":"22","author":"X Li","year":"2024","unstructured":"Li, X. et al. Glutamine addiction in tumor cell: oncogene regulation and clinical treatment. Cell Commun. Signal. 22, 12 (2024).","journal-title":"Cell Commun. Signal."},{"key":"2981_CR80","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.celrep.2016.09.045","volume":"17","author":"B Smith","year":"2016","unstructured":"Smith, B. et al. Addiction to coupling of the warburg effect with glutamine catabolism in cancer cells. Cell Rep. 17, 821\u2013836 (2016).","journal-title":"Cell Rep."},{"key":"2981_CR81","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.bbcan.2018.07.007","volume":"1870","author":"JM Mat\u00e9s","year":"2018","unstructured":"Mat\u00e9s, J. M., Campos-Sandoval, J. A. & M\u00e1rquez, J. Glutaminase isoenzymes in the metabolic therapy of cancer. Biochim. Biophys. Acta (BBA) - Rev. Cancer 1870, 158\u2013164 (2018).","journal-title":"Biochim. Biophys. Acta (BBA) - Rev. Cancer"},{"key":"2981_CR82","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1002\/med.21766","volume":"41","author":"HJ Cardoso","year":"2020","unstructured":"Cardoso, H. J. et al. Revisiting prostate cancer metabolism: from metabolites to disease and therapy. Med. Res. Rev. 41, 1499\u20131538 (2020).","journal-title":"Med. Res. Rev."},{"key":"2981_CR83","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.semcdb.2019.05.012","volume":"98","author":"JM Mat\u00e9s","year":"2020","unstructured":"Mat\u00e9s, J. M. et al. Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer. Semin. Cell Dev. Biol. 98, 34\u201343 (2020).","journal-title":"Semin. Cell Dev. Biol."},{"key":"2981_CR84","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/path.4429","volume":"235","author":"P Ren","year":"2014","unstructured":"Ren, P. et al. ATF4 and N-Myc coordinate glutamine metabolism in MYCN-amplified neuroblastoma cells through ASCT2 activation. J. Pathol. 235, 90\u2013100 (2014).","journal-title":"J. Pathol."},{"key":"2981_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.608641","volume":"11","author":"J Zhao","year":"2021","unstructured":"Zhao, J. et al. Correlation between prognostic biomarker SLC1A5 and immune infiltrates in various types of cancers including hepatocellular carcinoma. Front. Oncol. 11, 608641 (2021).","journal-title":"Front. Oncol."},{"key":"2981_CR86","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41418-024-01323-4","volume":"31","author":"X Shi","year":"2024","unstructured":"Shi, X. et al. The tRNA Gm18 methyltransferase TARBP1 promotes hepatocellular carcinoma progression via metabolic reprogramming of glutamine. Cell Death Differ. 31, 1219\u20131234 (2024).","journal-title":"Cell Death Differ."},{"key":"2981_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115446","volume":"209","author":"X Mo","year":"2023","unstructured":"Mo, X. et al. CEMIP promotes small cell lung cancer proliferation by activation of glutamine metabolism via FBXW7\/c-Myc-dependent axis. Biochem. Pharmacol. 209, 115446 (2023).","journal-title":"Biochem. Pharmacol."},{"key":"2981_CR88","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1007\/s00535-025-02305-0","volume":"60","author":"W Zhu","year":"2025","unstructured":"Zhu, W. et al. Inhibition of integrin \u03b13 suppresses gastric cancer progression via STAT3-mediated regulation of SLC1A5-dependent glutamine uptake. J. Gastroenterol. 60, 1496\u20131512 (2025).","journal-title":"J. Gastroenterol."},{"key":"2981_CR89","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41588-020-00753-3","volume":"53","author":"AK Najumudeen","year":"2021","unstructured":"Najumudeen, A. K. et al. The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer. Nat. Genet. 53, 16\u201326 (2021).","journal-title":"Nat. Genet."},{"key":"2981_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38594-3","volume":"14","author":"X Zhu","year":"2023","unstructured":"Zhu, X. et al. Alanine supplementation exploits glutamine dependency induced by SMARCA4\/2-loss. Nat. Commun. 14, 2894 (2023).","journal-title":"Nat. Commun."},{"key":"2981_CR91","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/s41586-026-10268-2","volume":"653","author":"F Hecht","year":"2026","unstructured":"Hecht, F. et al. Catabolism of extracellular glutathione supplies cysteine to support tumours. Nature 653, 933\u2013941 (2026).","journal-title":"Nature"},{"key":"2981_CR92","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1038\/s12276-025-01596-w","volume":"57","author":"HW Kang","year":"2025","unstructured":"Kang, H. W. et al. SLC6A14-mediated glutamine promotes SYTL4\u2013CXCL8 axis activation to drive gemcitabine resistance and immune evasion in pancreatic cancer. Exp. Mol. Med. 57, 2943\u20132956 (2025).","journal-title":"Exp. Mol. Med."},{"key":"2981_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39401-9","volume":"14","author":"Y Yan","year":"2023","unstructured":"Yan, Y. et al. SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells. Nat. Commun. 14, 3673 (2023).","journal-title":"Nat. Commun."},{"key":"2981_CR94","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ebiom.2019.01.036","volume":"40","author":"J-S Lee","year":"2019","unstructured":"Lee, J.-S. et al. Loss of SLC25A11 causes suppression of NSCLC and melanoma tumor formation. EBioMedicine 40, 184\u2013197 (2019).","journal-title":"EBioMedicine"},{"key":"2981_CR95","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1053\/j.gastro.2016.07.011","volume":"151","author":"CC Wong","year":"2016","unstructured":"Wong, C. C. et al. SLC25A22 promotes proliferation and survival of colorectal cancer cells with kras mutations and xenograft tumor progression in mice via intracellular synthesis of aspartate. Gastroenterology 151, 945\u2013960.e946 (2016).","journal-title":"Gastroenterology"},{"key":"2981_CR96","doi-asserted-by":"publisher","first-page":"1578940","DOI":"10.3389\/fimmu.2025.1578940","volume":"16","author":"L Fang","year":"2025","unstructured":"Fang, L. et al. Glutamine\u2019s double-edged sword: fueling tumor growth and offering therapeutic hope. Front. Immunol. 16, 1578940 (2025).","journal-title":"Front. Immunol."},{"key":"2981_CR97","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4155\/fmc-2016-0190","volume":"9","author":"WP Katt","year":"2017","unstructured":"Katt, W. P., Lukey, M. J. & Cerione, R. A. A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis. Future Med. Chem. 9, 223\u2013243 (2017).","journal-title":"Future Med. Chem."},{"key":"2981_CR98","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41388-019-1007-z","volume":"39","author":"MM Dias","year":"2019","unstructured":"Dias, M. M. et al. GLS2 is protumorigenic in breast cancers. Oncogene 39, 690\u2013702 (2019).","journal-title":"Oncogene"},{"key":"2981_CR99","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1038\/s41388-022-02408-5","volume":"41","author":"L-E Quek","year":"2022","unstructured":"Quek, L.-E. et al. Glutamine addiction promotes glucose oxidation in triple-negative breast cancer. Oncogene 41, 4066\u20134078 (2022).","journal-title":"Oncogene"},{"key":"2981_CR100","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/s41586-026-10216-0","volume":"652","author":"AAH Patel","year":"2026","unstructured":"Patel, A. A. H. et al. Ageing promotes metastasis via activation of the integrated stress response. Nature 652, 1339\u20131348 (2026).","journal-title":"Nature"},{"key":"2981_CR101","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","volume":"40","author":"H Weng","year":"2022","unstructured":"Weng, H. et al. The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. Cancer Cell. 40, 1566\u20131582.e1510 (2022).","journal-title":"Cancer Cell."},{"key":"2981_CR102","doi-asserted-by":"publisher","first-page":"7844","DOI":"10.7150\/thno.58655","volume":"11","author":"A Mukha","year":"2021","unstructured":"Mukha, A. et al. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy. Theranostics 11, 7844\u20137868 (2021).","journal-title":"Theranostics"},{"key":"2981_CR103","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jhep.2023.10.024","volume":"80","author":"Q Zhang","year":"2024","unstructured":"Zhang, Q. et al. Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism. J. Hepatol. 80, 293\u2013308 (2024).","journal-title":"J. Hepatol."},{"key":"2981_CR104","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.jhep.2019.12.015","volume":"72","author":"W Dai","year":"2020","unstructured":"Dai, W. et al. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism. J. Hepatol. 72, 909\u2013923 (2020).","journal-title":"J. Hepatol."},{"key":"2981_CR105","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.172336","volume":"9","author":"KR Kami Reddy","year":"2024","unstructured":"Kami Reddy, K. R. et al. Mitochondrial reprogramming by activating OXPHOS via glutamine metabolism in African American patients with bladder cancer. JCI Insight 9, e172336 (2024).","journal-title":"JCI Insight"},{"key":"2981_CR106","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abp8293","volume":"8","author":"AK Kaushik","year":"2022","unstructured":"Kaushik, A. K. et al. In vivo characterization of glutamine metabolism identifies therapeutic targets in clear cell renal cell carcinoma. Sci. Adv. 8, eabp8293 (2022).","journal-title":"Sci. Adv."},{"key":"2981_CR107","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1165\/rcmb.2019-0008OC","volume":"61","author":"RB Hamanaka","year":"2019","unstructured":"Hamanaka, R. B. et al. Glutamine metabolism is required for collagen protein synthesis in lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 61, 597\u2013606 (2019).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2981_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.216040","volume":"555","author":"H Liu","year":"2023","unstructured":"Liu, H. et al. Pancreatic stellate cells exploit Wnt\/\u03b2-catenin\/TCF7-mediated glutamine metabolism to promote pancreatic cancer cells growth. Cancer Lett. 555, 216040 (2023).","journal-title":"Cancer Lett."},{"key":"2981_CR109","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1158\/1535-7163.MCT-20-0271","volume":"19","author":"R Rashmi","year":"2020","unstructured":"Rashmi, R. et al. Glutaminase inhibitors induce thiol-mediated oxidative stress and radiosensitization in treatment-resistant cervical cancers. Mol. Cancer Ther. 19, 2465\u20132475 (2020).","journal-title":"Mol. Cancer Ther."},{"key":"2981_CR110","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1158\/0008-5472.CAN-19-1363","volume":"80","author":"S Mukhopadhyay","year":"2020","unstructured":"Mukhopadhyay, S. et al. Undermining glutaminolysis bolsters chemotherapy while NRF2 promotes chemoresistance in KRAS-driven pancreatic cancers. Cancer Res. 80, 1630\u20131643 (2020).","journal-title":"Cancer Res."},{"key":"2981_CR111","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.94543","volume":"3","author":"WI Gonsalves","year":"2018","unstructured":"Gonsalves, W. I. et al. Glutamine-derived 2-hydroxyglutarate is associated with disease progression in plasma cell malignancies. JCI Insight 3, e94543 (2018).","journal-title":"JCI Insight"},{"key":"2981_CR112","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41556-021-00820-9","volume":"24","author":"D Huang","year":"2022","unstructured":"Huang, D. et al. Cancer-cell-derived GABA promotes \u03b2-catenin-mediated tumour growth and immunosuppression. Nat. Cell Biol. 24, 230\u2013241 (2022).","journal-title":"Nat. Cell Biol."},{"key":"2981_CR113","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70131","volume":"14","author":"C He","year":"2024","unstructured":"He, C. et al. Microenvironmental G protein-coupled estrogen receptor-mediated glutamine metabolic coupling between cancer-associated fibroblasts and triple-negative breast cancer cells governs tumour progression. Clin. Transl. Med. 14, e70131 (2024).","journal-title":"Clin. Transl. Med."},{"key":"2981_CR114","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1172\/JCI99397","volume":"128","author":"R Mishra","year":"2018","unstructured":"Mishra, R. et al. Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming. J. Clin. Investig. 128, 4472\u20134484 (2018).","journal-title":"J. Clin. Investig."},{"key":"2981_CR115","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12951-023-01979-z","volume":"21","author":"C Ai","year":"2023","unstructured":"Ai, C. et al. CAFs targeted ultrasound-responsive nanodroplets loaded V9302 and GLULsiRNA to inhibit melanoma growth via glutamine metabolic reprogramming and tumor microenvironment remodeling. J. Nanobiotechnol. 21, 214 (2023).","journal-title":"J. Nanobiotechnol."},{"key":"2981_CR116","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1126\/science.aav2588","volume":"366","author":"RD Leone","year":"2019","unstructured":"Leone, R. D. et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science 366, 1013\u20131021 (2019).","journal-title":"Science"},{"key":"2981_CR117","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/s12276-024-01214-1","volume":"56","author":"D-H Kim","year":"2024","unstructured":"Kim, D.-H. et al. Glutamine-derived aspartate is required for eIF5A hypusination-mediated translation of HIF-1\u03b1 to induce the polarization of tumor-associated macrophages. Exp. Mol. Med. 56, 1123\u20131136 (2024).","journal-title":"Exp. Mol. Med."},{"key":"2981_CR118","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202400738","volume":"9","author":"T Li","year":"2025","unstructured":"Li, T. et al. Inhibition of glutamine metabolism attenuates tumor progression through remodeling of the macrophage immune microenvironment. Adv. Biol. 9, e00738 (2025).","journal-title":"Adv. Biol."},{"key":"2981_CR119","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1172\/JCI131859","volume":"130","author":"M-H Oh","year":"2020","unstructured":"Oh, M.-H. et al. Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells. J. Clin. Investig. 130, 3865\u20133884 (2020).","journal-title":"J. Clin. Investig."},{"key":"2981_CR120","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140100","volume":"131","author":"DN Edwards","year":"2021","unstructured":"Edwards, D. N. et al. Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer. J. Clin. Investig. 131, e140100 (2021).","journal-title":"J. Clin. Investig."},{"key":"2981_CR121","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.eururo.2018.09.030","volume":"75","author":"Q Fu","year":"2019","unstructured":"Fu, Q. et al. Tumor-associated macrophage-derived interleukin-23 interlinks kidney cancer glutamine addiction with immune evasion. Eur. Urol. 75, 752\u2013763 (2019).","journal-title":"Eur. Urol."},{"key":"2981_CR122","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41590-024-01755-7","volume":"25","author":"T Wertheimer","year":"2024","unstructured":"Wertheimer, T. et al. IL-23 stabilizes an effector Treg cell program in the tumor microenvironment. Nat. Immunol. 25, 512\u2013524 (2024).","journal-title":"Nat. Immunol."},{"key":"2981_CR123","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1599252","volume":"16","author":"J Fan","year":"2025","unstructured":"Fan, J. et al. Suppressing glutamine metabolism in the pancreatic cancer microenvironment can enhance the anti-tumor effect of CD8 T cells and promote the efficacy of immunotherapy. Front. Immunol. 16, 1599252 (2025).","journal-title":"Front. Immunol."},{"key":"2981_CR124","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiae243","volume":"117","author":"KEM Hellenthal","year":"2025","unstructured":"Hellenthal, K. E. M. et al. Glutamine modulates neutrophil recruitment and effector functions during sterile inflammation. J. Leukoc. Biol. 117, qiae243 (2025).","journal-title":"J. Leukoc. Biol."},{"key":"2981_CR125","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/j.ccell.2025.07.014","volume":"43","author":"D Chen","year":"2025","unstructured":"Chen, D. et al. DNASE1L3-expressing dendritic cells promote CD8+ T cell function and anti-PD-(L)1 therapy efficacy by degrading neutrophil extracellular traps. Cancer Cell. 43, 1758\u20131775.e1758 (2025).","journal-title":"Cancer Cell."},{"key":"2981_CR126","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41586-023-06299-8","volume":"620","author":"C Guo","year":"2023","unstructured":"Guo, C. et al. SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity. Nature 620, 200\u2013208 (2023).","journal-title":"Nature"},{"key":"2981_CR127","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aab2610","volume":"8","author":"D Klysz","year":"2015","unstructured":"Klysz, D. et al. Glutamine-dependent \u03b1-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation. Science Signaling 8, ra97 (2015).","journal-title":"Science Signaling"},{"key":"2981_CR128","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41590-025-02153-3","volume":"26","author":"TJ Sanders","year":"2025","unstructured":"Sanders, T. J. et al. Inhibition of ENT1 relieves intracellular adenosine-mediated T\u2009cell suppression in cancer. Nat. Immunol. 26, 854\u2013865 (2025).","journal-title":"Nat. Immunol."},{"key":"2981_CR129","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.ccell.2019.10.007","volume":"36","author":"D Boison","year":"2019","unstructured":"Boison, D. & Yegutkin, G. G. Adenosine metabolism: emerging concepts for cancer therapy. Cancer Cell 36, 582\u2013596 (2019).","journal-title":"Cancer Cell"},{"key":"2981_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109911","volume":"37","author":"MI Matias","year":"2021","unstructured":"Matias, M. I. et al. Regulatory T cell differentiation is controlled by \u03b1KG-induced alterations in mitochondrial metabolism and lipid homeostasis. Cell Rep. 37, 109911 (2021).","journal-title":"Cell Rep."},{"key":"2981_CR131","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1182\/blood.V90.4.1600","volume":"90","author":"S Huang","year":"1997","unstructured":"Huang, S., Apasov, S., Koshiba, M. & Sitkovsky, M. Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 90, 1600\u20131610 (1997).","journal-title":"Blood"},{"key":"2981_CR132","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1096\/fj.08-107458","volume":"22","author":"B Cs\u00f3ka","year":"2008","unstructured":"Cs\u00f3ka, B. et al. Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function. FASEB J. 22, 3491\u20133499 (2008).","journal-title":"FASEB J."},{"key":"2981_CR133","doi-asserted-by":"publisher","first-page":"13132","DOI":"10.1073\/pnas.0605251103","volume":"103","author":"A Ohta","year":"2006","unstructured":"Ohta, A. et al. A2A adenosine receptor protects tumors from antitumor T cells. Proc. Natl. Acad. Sci. 103, 13132\u201313137 (2006).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"2981_CR134","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","volume":"9","author":"MA Kumar","year":"2024","unstructured":"Kumar, M. A. et al. Extracellular vesicles as tools and targets in therapy for diseases. Signal Transduct. Target. Ther. 9, 27 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2981_CR135","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1136\/gutjnl-2024-332429","volume":"74","author":"Y Yang","year":"2025","unstructured":"Yang, Y. et al. Glutamine metabolic competition drives immunosuppressive reprogramming of intratumour GPR109A+ myeloid cells to promote liver cancer progression. Gut. 74, 255\u2013269 (2025).","journal-title":"Gut."},{"key":"2981_CR136","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.800","volume":"12","author":"W He","year":"2022","unstructured":"He, W. et al. Hepatocellular carcinoma-infiltrating \u03b3\u03b4 T cells are functionally defected and allogenic V\u03b42+ \u03b3\u03b4 T cell can be a promising complement. Clin. Transl. Med. 12, e800 (2022).","journal-title":"Clin. Transl. Med."},{"key":"2981_CR137","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.cmet.2022.04.003","volume":"34","author":"SA Best","year":"2022","unstructured":"Best, S. A. et al. Glutaminase inhibition impairs CD8 T cell activation in STK11-\/Lkb1-deficient lung cancer. Cell Metab. 34, 874\u2013887.e876 (2022).","journal-title":"Cell Metab."},{"key":"2981_CR138","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-026-07705-1","volume":"24","author":"G Ma","year":"2026","unstructured":"Ma, G. et al. Inhibition of glutamine metabolism blocks tumor growth and sensitizes ccRCC to immune checkpoint blockade. J. Transl. Med. 24, 309 (2026).","journal-title":"J. Transl. Med."},{"key":"2981_CR139","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1158\/2326-6066.CIR-18-0902","volume":"7","author":"W-C Wu","year":"2019","unstructured":"Wu, W.-C. et al. Immunosuppressive immature myeloid cell generation is controlled by glutamine metabolism in human cancer. Cancer Immunol. Res. 7, 1605\u20131618 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"2981_CR140","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/cac2.12459","volume":"43","author":"X Hu","year":"2023","unstructured":"Hu, X. et al. Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2-positive gastric cancer. Cancer Commun 43, 909\u2013937 (2023).","journal-title":"Cancer Commun"},{"key":"2981_CR141","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202051981","volume":"22","author":"A Menga","year":"2021","unstructured":"Menga, A. et al. N-acetylaspartate release by glutaminolytic ovarian cancer cells sustains protumoral macrophages. EMBO Rep. 22, EMBR202051981 (2021).","journal-title":"EMBO Rep."},{"key":"2981_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215710","volume":"538","author":"L Shen","year":"2022","unstructured":"Shen, L. et al. Metabolic reprogramming by ex vivo glutamine inhibition endows CAR-T cells with less-differentiated phenotype and persistent antitumor activity. Cancer Lett. 538, 215710 (2022).","journal-title":"Cancer Lett."},{"key":"2981_CR143","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.molcel.2020.10.015","volume":"80","author":"J-K Byun","year":"2020","unstructured":"Byun, J.-K. et al. Inhibition of glutamine utilization synergizes with immune checkpoint inhibitor to promote antitumor immunity. Mol. Cell. 80, 592\u2013606.e598 (2020).","journal-title":"Mol. Cell."},{"key":"2981_CR144","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1158\/2326-6066.CIR-24-0039","volume":"13","author":"G Ma","year":"2025","unstructured":"Ma, G. et al. Gefitinib reverses PD-L1\u2013mediated immunosuppression induced by long-term glutamine blockade in bladder cancer. Cancer Immunol. Res. 13, 66\u201383 (2025).","journal-title":"Cancer Immunol. Res."},{"key":"2981_CR145","doi-asserted-by":"publisher","first-page":"1643017","DOI":"10.3389\/fimmu.2025.1643017","volume":"16","author":"F Du","year":"2025","unstructured":"Du, F. et al. Glutamine metabolism and ammonia death: targeted modulation for enhanced cancer immunotherapy. Front. Immunol. 16, 1643017 (2025).","journal-title":"Front. Immunol."},{"key":"2981_CR146","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.15252\/embj.201695518","volume":"36","author":"H Huang","year":"2017","unstructured":"Huang, H. et al. Role of glutamine and interlinked asparagine metabolism in vessel formation. EMBO J. 36, 2334\u20132352 (2017).","journal-title":"EMBO J."},{"key":"2981_CR147","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nm.4464","volume":"24","author":"ML Schulte","year":"2018","unstructured":"Schulte, M. L. et al. Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models. Nat. Med. 24, 194\u2013202 (2018).","journal-title":"Nat. Med."},{"key":"2981_CR148","doi-asserted-by":"publisher","DOI":"10.34133\/research.0858","volume":"8","author":"X Wei","year":"2025","unstructured":"Wei, X. et al. Delivery-graded programmable micelles achieve enhanced tumor starvation through combined glutamine deprivation and angiogenesis inhibition. Research 8, 0858 (2025).","journal-title":"Research"},{"key":"2981_CR149","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06657-2","volume":"23","author":"C Sun","year":"2025","unstructured":"Sun, C. et al. Sympathetic nervous system in tumor progression and metabolic regulation: mechanisms and clinical potential. J. Transl. Med. 23, 836 (2025).","journal-title":"J. Transl. Med."},{"key":"2981_CR150","doi-asserted-by":"publisher","first-page":"114943","DOI":"10.1016\/j.bcp.2022.114943","volume":"198","author":"S Sharma","year":"2022","unstructured":"Sharma, S., Agnihotri, N. & Kumar, S. Targeting fuel pocket of cancer cell metabolism: a focus on glutaminolysis. Biochem. Pharmacol. 198, 114943 (2022).","journal-title":"Biochem. Pharmacol."},{"key":"2981_CR151","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41420-021-00792-7","volume":"7","author":"S Hwang","year":"2021","unstructured":"Hwang, S. et al. Mitochondrial glutamine metabolism regulates sensitivity of cancer cells after chemotherapy via amphiregulin. Cell Death Discov. 7, 395 (2021).","journal-title":"Cell Death Discov."},{"key":"2981_CR152","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14374-1","volume":"11","author":"P Lee","year":"2020","unstructured":"Lee, P. et al. Targeting glutamine metabolism slows soft tissue sarcoma growth. Nat. Commun. 11, 498 (2020).","journal-title":"Nat. Commun."},{"key":"2981_CR153","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1158\/1078-0432.CCR-18-3223","volume":"25","author":"MA Gregory","year":"2019","unstructured":"Gregory, M. A. et al. Targeting glutamine metabolism and redox state for leukemia therapy. Clin. Cancer Res. 25, 4079\u20134090 (2019).","journal-title":"Clin. Cancer Res."},{"key":"2981_CR154","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1158\/1535-7163.MCT-18-0985","volume":"18","author":"NM Zacharias","year":"2019","unstructured":"Zacharias, N. M. et al. Assessing metabolic intervention with a glutaminase inhibitor in real-time by hyperpolarized magnetic resonance in acute myeloid leukemia. Mol. Cancer Ther. 18, 1937\u20131946 (2019).","journal-title":"Mol. Cancer Ther."},{"key":"2981_CR155","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06041-2","volume":"14","author":"Y Hwang","year":"2023","unstructured":"Hwang, Y. et al. Co-inhibition of glutaminolysis and one-carbon metabolism promotes ROS accumulation leading to enhancement of chemotherapeutic efficacy in anaplastic thyroid cancer. Cell Death Dis. 14, 515 (2023).","journal-title":"Cell Death Dis."},{"key":"2981_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2025.111812","volume":"423","author":"H Wang","year":"2026","unstructured":"Wang, H. et al. GLS1 inhibitor CB-839 inhibits the malignant progression of 5-FU resistant hepatoma cells by regulating glutamine metabolism. Chem. Biol. Interact. 423, 111812 (2026).","journal-title":"Chem. Biol. Interact."},{"key":"2981_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103813","volume":"86","author":"B Gao","year":"2025","unstructured":"Gao, B. et al. Asparagine synthetase modulates glutaminase inhibitor sensitivity through metabolic reprogramming and serves as a prognostic biomarker in hepatocellular carcinoma. Redox Biol. 86, 103813 (2025).","journal-title":"Redox Biol."},{"key":"2981_CR158","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1158\/0008-5472.CAN-22-0042","volume":"82","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. GOT2 silencing promotes reprogramming of glutamine metabolism and sensitizes hepatocellular carcinoma to glutaminase inhibitors. Cancer Res. 82, 3223\u20133235 (2022).","journal-title":"Cancer Res."},{"key":"2981_CR159","doi-asserted-by":"publisher","first-page":"4994","DOI":"10.1158\/1078-0432.CCR-21-1204","volume":"27","author":"JJ Harding","year":"2021","unstructured":"Harding, J. J. et al. A phase I dose-escalation and expansion study of telaglenastat in patients with advanced or metastatic solid tumors. Clin. Cancer Res. 27, 4994\u20135003 (2021).","journal-title":"Clin. Cancer Res."},{"key":"2981_CR160","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1001\/jamaoncol.2022.3511","volume":"8","author":"NM Tannir","year":"2022","unstructured":"Tannir, N. M. et al. Efficacy and safety of telaglenastat plus cabozantinib vs placebo plus cabozantinib in patients with advanced renal cell carcinoma. JAMA Oncol. 8, 1411 (2022).","journal-title":"JAMA Oncol."},{"key":"2981_CR161","doi-asserted-by":"publisher","first-page":"E5328","DOI":"10.1073\/pnas.1611406113","volume":"113","author":"A Elgogary","year":"2016","unstructured":"Elgogary, A. et al. Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer. Proc. Natl. Acad. Sci. 113, E5328\u2013E5336 (2016).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"2981_CR162","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ccell.2014.12.006","volume":"27","author":"L Jin","year":"2015","unstructured":"Jin, L. et al. Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth. Cancer Cell 27, 257\u2013270 (2015).","journal-title":"Cancer Cell"},{"key":"2981_CR163","doi-asserted-by":"publisher","first-page":"100085","DOI":"10.1016\/j.arres.2023.100085","volume":"9","author":"A Sehgal","year":"2023","unstructured":"Sehgal, A. et al. EGCG: The antioxidant powerhouse in lung cancer management and chemotherapy enhancement. Adv. Redox Res. 9, 100085 (2023).","journal-title":"Adv. Redox Res."},{"key":"2981_CR164","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11033-025-11172-0","volume":"53","author":"R Liu","year":"2025","unstructured":"Liu, R. et al. Inhibition of glutamine synthetase enhances hepatocellular carcinoma radiosensitivity through ROS-induced excessive mitophagy. Mol. Biol. Rep. 53, 5 (2025).","journal-title":"Mol. Biol. Rep."},{"key":"2981_CR165","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1007\/s00726-011-0981-4","volume":"42","author":"S Tardito","year":"2011","unstructured":"Tardito, S. et al. The non-proteinogenic amino acids l-methionine sulfoximine and dl-phosphinothricin activate mTOR. Amino Acids 42, 2507\u20132512 (2011).","journal-title":"Amino Acids"},{"key":"2981_CR166","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3109\/14756366.2015.1070846","volume":"31","author":"P Kosikowska","year":"2015","unstructured":"Kosikowska, P. et al. Bisphosphonic acids as effective inhibitors of Mycobacterium tuberculosisglutamine synthetase. J. Enzyme Inhib. Med. Chem. 31, 931\u2013938 (2015).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"2981_CR167","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s00726-017-2436-z","volume":"49","author":"M Chiu","year":"2017","unstructured":"Chiu, M. et al. GPNA inhibits the sodium-independent transport system l for neutral amino acids. Amino Acids 49, 1365\u20131372 (2017).","journal-title":"Amino Acids"},{"key":"2981_CR168","doi-asserted-by":"publisher","first-page":"17854","DOI":"10.1021\/jacs.4c03478","volume":"146","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Dual starvations induce pyroptosis for orthotopic pancreatic cancer therapy through simultaneous deprivation of glucose and glutamine. J. Am. Chem. Soc. 146, 17854\u201317865 (2024).","journal-title":"J. Am. Chem. Soc."},{"key":"2981_CR169","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.70969","volume":"15","author":"J Ding","year":"2026","unstructured":"Ding, J. et al. A Glutamine-metabolism-intervening nanoplatform activates lipophagy to potentiate ferroptosis and immune activation in breast cancer. Adv Healthc Mater 15, e70969 (2026).","journal-title":"Adv Healthc Mater"},{"key":"2981_CR170","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.canlet.2021.02.020","volume":"507","author":"MK Prelowska","year":"2021","unstructured":"Prelowska, M. K. et al. Inhibition of the \u029f-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitors. Cancer Lett. 507, 13\u201325 (2021).","journal-title":"Cancer Lett."},{"key":"2981_CR171","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1182\/blood.2021013990","volume":"140","author":"Z Chen","year":"2022","unstructured":"Chen, Z. et al. Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment. Blood 140, 630\u2013643 (2022).","journal-title":"Blood"},{"key":"2981_CR172","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1158\/1535-7163.MCT-20-0354","volume":"20","author":"Y Feng","year":"2021","unstructured":"Feng, Y. et al. Identification and characterization of IMD-0354 as a glutamine carrier protein inhibitor in melanoma. Mol. Cancer Ther. 20, 816\u2013832 (2021).","journal-title":"Mol. Cancer Ther."},{"key":"2981_CR173","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64730-2","volume":"16","author":"Y Sung","year":"2025","unstructured":"Sung, Y. et al. Targeting cancer glutamine dependency with a first-in-class inhibitor of the mitochondrial glutamine transporter SLC1A5_var. Nat. Commun. 16, 9690 (2025).","journal-title":"Nat. Commun."},{"key":"2981_CR174","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1251643","volume":"14","author":"R Huang","year":"2023","unstructured":"Huang, R. et al. Targeting glutamine metabolic reprogramming of SLC7A5 enhances the efficacy of anti-PD-1 in triple-negative breast cancer. Front. Immunol. 14, 1251643 (2023).","journal-title":"Front. Immunol."},{"key":"2981_CR175","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41416-020-01113-y","volume":"124","author":"M Morotti","year":"2020","unstructured":"Morotti, M. et al. Increased expression of glutamine transporter SNAT2\/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer. Br. J. Cancer 124, 494\u2013505 (2020).","journal-title":"Br. J. Cancer"},{"key":"2981_CR176","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cmet.2017.12.006","volume":"27","author":"NN Pavlova","year":"2018","unstructured":"Pavlova, N. N. et al. As extracellular glutamine levels decline, asparagine becomes an essential amino acid. Cell Metab 27, 428\u2013438.e425 (2018).","journal-title":"Cell Metab"},{"key":"2981_CR177","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1158\/1535-7163.MCT-18-1329","volume":"18","author":"W-K Chan","year":"2019","unstructured":"Chan, W.-K. et al. Glutaminase activity of L-asparaginase contributes to durable preclinical activity against acute lymphoblastic leukemia. Mol. Cancer Ther. 18, 1587\u20131592 (2019).","journal-title":"Mol. Cancer Ther."},{"key":"2981_CR178","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/cts.12947","volume":"14","author":"T Lin","year":"2021","unstructured":"Lin, T. et al. A Randomized phase I study to evaluate the safety, tolerability, and pharmacokinetics of recombinant Erwinia asparaginase (JZP-458) in healthy adult volunteers. Clin. Transl. Sci. 14, 870\u2013879 (2021).","journal-title":"Clin. Transl. Sci."},{"key":"2981_CR179","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1182\/blood.2022016923","volume":"141","author":"L Maese","year":"2023","unstructured":"Maese, L. et al. Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2\/3 AALL1931 study. Blood 141, 704\u2013712 (2023).","journal-title":"Blood"},{"key":"2981_CR180","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/j.molcel.2022.03.016","volume":"82","author":"B Jiang","year":"2022","unstructured":"Jiang, B. et al. Filamentous GLS1 promotes ROS-induced apoptosis upon glutamine deprivation via insufficient asparagine synthesis. Mol. Cell 82, 1821\u20131835.e1826 (2022).","journal-title":"Mol. Cell"},{"key":"2981_CR181","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.trecan.2021.04.003","volume":"7","author":"W-H Yang","year":"2021","unstructured":"Yang, W.-H. et al. Enhancing the efficacy of glutamine metabolism inhibitors in cancer therapy. Trends Cancer 7, 790\u2013804 (2021).","journal-title":"Trends Cancer"},{"key":"2981_CR182","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s42003-024-06262-x","volume":"7","author":"R Patel","year":"2024","unstructured":"Patel, R. et al. Targeting glutamine metabolism improves sarcoma response to radiation therapy in vivo. Commun. Biol. 7, 608 (2024).","journal-title":"Commun. Biol."},{"key":"2981_CR183","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216727","volume":"588","author":"A Song","year":"2024","unstructured":"Song, A. et al. Glutamine inhibition combined with CD47 blockade enhances radiotherapy-induced ferroptosis in head and neck squamous cell carcinoma. Cancer Lett. 588, 216727 (2024).","journal-title":"Cancer Lett."},{"key":"2981_CR184","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jconrel.2023.04.027","volume":"357","author":"L Zhao","year":"2023","unstructured":"Zhao, L. et al. Targeting glutamine metabolism with photodynamic immunotherapy for metastatic tumor eradication. J. Control. Release 357, 460\u2013471 (2023).","journal-title":"J. Control. Release"},{"key":"2981_CR185","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12951-022-01424-7","volume":"20","author":"Y Tang","year":"2022","unstructured":"Tang, Y. et al. Simultaneous glutamine metabolism and PD-L1 inhibition to enhance suppression of triple-negative breast cancer. J. Nanobiotechnol. 20, 216 (2022).","journal-title":"J. Nanobiotechnol."},{"key":"2981_CR186","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202309094","volume":"36","author":"XK Jin","year":"2023","unstructured":"Jin, X. K. et al. A PD-L1-targeting regulator for metabolic reprogramming to enhance glutamine inhibition-mediated synergistic antitumor metabolic and immune therapy. Adv. Mater. 36, 2309094 (2023).","journal-title":"Adv. Mater."},{"key":"2981_CR187","doi-asserted-by":"crossref","unstructured":"Zhuang, J. et al. HB023: A glutamine antagonist prodrug boosting antitumor lmmunity via PD-L1 suppression and mitochondrial membrane remodeling. J. Adv. Res., S2090123226001013 (2026).","DOI":"10.1016\/j.jare.2026.01.077"},{"key":"2981_CR188","doi-asserted-by":"publisher","first-page":"21836","DOI":"10.1021\/acsami.2c00111","volume":"14","author":"Y Xu","year":"2022","unstructured":"Xu, Y. et al. Dual inhibitions on glucose\/glutamine metabolisms for nontoxic pancreatic cancer therapy. ACS Appl. Mater. Interfaces. 14, 21836\u201321847 (2022).","journal-title":"ACS Appl. Mater. Interfaces."},{"key":"2981_CR189","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202303253","volume":"19","author":"H Du","year":"2023","unstructured":"Du, H. et al. Detachable MOF-based core\/shell nanoreactor for cancer dual-starvation therapy with reversing glucose and glutamine metabolisms. Small 19, 2303253 (2023).","journal-title":"Small"},{"key":"2981_CR190","doi-asserted-by":"publisher","first-page":"51659","DOI":"10.1021\/acsami.5c10711","volume":"17","author":"B Li","year":"2025","unstructured":"Li, B. et al. Metabolic inhibitor loaded metal\u2013phenolic nanocapsules enable synergistic cancer therapy through cuproptosis and immunometabolic reprogramming. ACS Appl. Mater. Interfaces 17, 51659\u201351670 (2025).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2981_CR191","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2022.100449","volume":"16","author":"Z Fu","year":"2022","unstructured":"Fu, Z. et al. Tumor-targeted dual-starvation therapy based on redox-responsive micelle nanosystem with co-loaded LND and BPTES. Mater. Today Bio. 16, 100449 (2022).","journal-title":"Mater. Today Bio."},{"key":"2981_CR192","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1038\/s41388-020-1235-2","volume":"39","author":"A Khan","year":"2020","unstructured":"Khan, A. et al. Targeting metabolic activity in high-risk neuroblastoma through monocarboxylate transporter 1 (MCT1) inhibition. Oncogene 39, 3555\u20133570 (2020).","journal-title":"Oncogene"},{"key":"2981_CR193","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.devcel.2025.02.012","volume":"60","author":"D Zhang","year":"2025","unstructured":"Zhang, D. et al. Glutamine binds HSC70 to transduce signals inhibiting IFN-\u03b2-mediated immunogenic cell death. Dev. Cell 60, 1958\u20131973.e1959 (2025).","journal-title":"Dev. Cell"},{"key":"2981_CR194","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq5925","volume":"8","author":"R Rais","year":"2022","unstructured":"Rais, R. et al. Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug. Sci. Adv. 8, eabq5925 (2022).","journal-title":"Sci. Adv."},{"key":"2981_CR195","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s43018-023-00647-3","volume":"5","author":"J Encarnaci\u00f3n-Rosado","year":"2023","unstructured":"Encarnaci\u00f3n-Rosado, J. et al. Targeting pancreatic cancer metabolic dependencies through glutamine antagonism. Nat. Cancer. 5, 85\u201399 (2023).","journal-title":"Nat. Cancer."},{"key":"2981_CR196","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154075","volume":"100","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Osmundacetone modulates mitochondrial metabolism in non-small cell lung cancer cells by hijacking the glutamine\/glutamate\/\u03b1-KG metabolic axis. Phytomedicine 100, 154075 (2022).","journal-title":"Phytomedicine"},{"key":"2981_CR197","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2967\/jnumed.120.261594","volume":"63","author":"AS Cohen","year":"2022","unstructured":"Cohen, A. S. et al. First-in-human PET imaging and estimated radiation dosimetry of l-[5-11C]-glutamine in patients with metastatic colorectal cancer. J. Nucl. Med. 63, 36\u201343 (2022).","journal-title":"J. Nucl. Med."},{"key":"2981_CR198","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1158\/1078-0432.CCR-24-3133","volume":"31","author":"KK Ciombor","year":"2025","unstructured":"Ciombor, K. K. et al. Results of the phase I\/II study and preliminary B-cell gene signature of combined inhibition of glutamine metabolism and EGFR in colorectal cancer. Clin. Cancer Res. 31, 1437\u20131448 (2025).","journal-title":"Clin. Cancer Res."},{"key":"2981_CR199","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115101","volume":"202","author":"B Zhang","year":"2022","unstructured":"Zhang, B. et al. Ginsenoside CK induces apoptosis in triple-negative breast cancer cells by targeting glutamine metabolism. Biochem. Pharmacol. 202, 115101 (2022).","journal-title":"Biochem. Pharmacol."},{"key":"2981_CR200","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157680","volume":"150","author":"Y Han","year":"2026","unstructured":"Han, Y. et al. Jianpi Jiedu formula modulates glutamine metabolism to inhibit colorectal cancer liver metastasis. Phytomedicine 150, 157680 (2026).","journal-title":"Phytomedicine"},{"key":"2981_CR201","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115253","volume":"205","author":"W Li","year":"2022","unstructured":"Li, W. et al. Lithocholic acid inhibits gallbladder cancer proliferation through interfering glutaminase-mediated glutamine metabolism. Biochem. Pharmacol. 205, 115253 (2022).","journal-title":"Biochem. Pharmacol."},{"key":"2981_CR202","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/advances\/nmy084","volume":"10","author":"W Ren","year":"2019","unstructured":"Ren, W. et al. Glutamine metabolism in macrophages: a novel target for obesity\/type 2 diabetes. Adv. Nutr. 10, 321\u2013330 (2019).","journal-title":"Adv. Nutr."},{"key":"2981_CR203","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/ni.3796","volume":"18","author":"P-S Liu","year":"2017","unstructured":"Liu, P.-S. et al. \u03b1-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nat. Immunol. 18, 985\u2013994 (2017).","journal-title":"Nat. Immunol."},{"key":"2981_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2025.101683","volume":"20","author":"X Han","year":"2026","unstructured":"Han, X. et al. The glutamine metabolic switch influences the response of neonatal intestinal macrophages to breast milk. Cell. Mol. Gastroenterol. Hepatol. 20, 101683 (2026).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"2981_CR205","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43304-0","volume":"14","author":"S Parveen","year":"2023","unstructured":"Parveen, S. et al. Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis. Nat. Commun. 14, 7427 (2023).","journal-title":"Nat. Commun."},{"key":"2981_CR206","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2025.2454323","volume":"16","author":"HW Kim","year":"2025","unstructured":"Kim, H. W. et al. Restriction of mitochondrial oxidation of glutamine or fatty acids enhances intracellular growth of Mycobacterium abscessus in macrophages. Virulence 16, 2454323 (2025).","journal-title":"Virulence"},{"key":"2981_CR207","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1089\/ars.2016.6715","volume":"26","author":"EM Palmieri","year":"2017","unstructured":"Palmieri, E. M. et al. Blockade of glutamine synthetase enhances inflammatory response in microglial cells. Antioxid. Redox Signal. 26, 351\u2013363 (2017).","journal-title":"Antioxid. Redox Signal."},{"key":"2981_CR208","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adn2635","volume":"17","author":"N Liu","year":"2025","unstructured":"Liu, N. et al. Itaconate restrains acute proinflammatory activation of microglia MG after traumatic brain injury in mice. Sci. Transl. Med. 17, eadn2635 (2025).","journal-title":"Sci. Transl. Med."},{"key":"2981_CR209","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.117443","volume":"242","author":"X Du","year":"2025","unstructured":"Du, X. et al. Targeting glutamine catabolism suppresses eosinophil expansion and activation to alleviate allergic airway inflammation. Biochem. Pharmacol. 242, 117443 (2025).","journal-title":"Biochem. Pharmacol."},{"key":"2981_CR210","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111516","volume":"41","author":"A Kumar","year":"2022","unstructured":"Kumar, A. et al. NKT cells adopt a glutamine-addicted phenotype to regulate their homeostasis and function. Cell Rep. 41, 111516 (2022).","journal-title":"Cell Rep."},{"key":"2981_CR211","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00018-022-04639-x","volume":"79","author":"S-L Yang","year":"2022","unstructured":"Yang, S.-L. et al. An active glutamine\/\u03b1-ketoglutarate\/HIF-1\u03b1 axis prevents pregnancy loss by triggering decidual IGF1+GDF15+NK cell differentiation. Cell. Mol. Life Sci. 79, 611 (2022).","journal-title":"Cell. Mol. Life Sci."},{"key":"2981_CR212","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13702","volume":"57","author":"ST Lei","year":"2024","unstructured":"Lei, S. T. et al. Abnormal HCK\/glutamine\/autophagy axis promotes endometriosis development by impairing macrophage phagocytosis. Cell Prolif. 57, e13702 (2024).","journal-title":"Cell Prolif."},{"key":"2981_CR213","doi-asserted-by":"publisher","first-page":"13075","DOI":"10.1073\/pnas.1516544112","volume":"112","author":"EB Gordon","year":"2015","unstructured":"Gordon, E. B. et al. Targeting glutamine metabolism rescues mice from late-stage cerebral malaria. Proc. Natl. Acad. Sci. 112, 13075\u201313080 (2015).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"2981_CR214","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.jcmgh.2023.01.004","volume":"15","author":"T Lu","year":"2023","unstructured":"Lu, T. et al. Gut microbiota-derived glutamine attenuates liver ischemia\/reperfusion injury via macrophage metabolic reprogramming. Cell. Mol. Gastroenterol. Hepatol. 15, 1255\u20131275 (2023).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"2981_CR215","doi-asserted-by":"publisher","first-page":"986847","DOI":"10.3389\/fimmu.2022.986847","volume":"13","author":"X Feng","year":"2022","unstructured":"Feng, X. et al. Glutaminolysis and CD4+ T-cell metabolism in autoimmunity: from pathogenesis to therapy prospects. Front. Immunol. 13, 986847 (2022).","journal-title":"Front. Immunol."},{"key":"2981_CR216","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.jaci.2025.07.018","volume":"156","author":"M Kabha","year":"2025","unstructured":"Kabha, M. et al. CARMIL2 deficiency disrupts activation-induced metabolic reprogramming in T cells and is partially rescued by glutamine supplementation. J. Allergy Clin. Immunol. 156, 1390\u20131400 (2025).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2981_CR217","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1182\/blood.2024027496","volume":"146","author":"F Navarro","year":"2025","unstructured":"Navarro, F. et al. Reprogramming glutamine metabolism enhances BCMA-CAR T-cell fitness and therapeutic efficacy in multiple myeloma. Blood 146, 2931\u20132944 (2025).","journal-title":"Blood"},{"key":"2981_CR218","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115767","volume":"216","author":"W Li","year":"2023","unstructured":"Li, W. et al. ASCT2-mediated glutamine uptake promotes Th1 differentiation via ROS-EGR1-PAC1 pathway in oral lichen planus. Biochem. Pharmacol. 216, 115767 (2023).","journal-title":"Biochem. Pharmacol."},{"key":"2981_CR219","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.880262","volume":"13","author":"Q Yu","year":"2022","unstructured":"Yu, Q. et al. Targeting glutamine metabolism ameliorates autoimmune hepatitis via inhibiting T cell activation and differentiation. Front. Immunol. 13, 880262 (2022).","journal-title":"Front. Immunol."},{"key":"2981_CR220","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1016\/j.immuni.2023.07.014","volume":"56","author":"EE West","year":"2023","unstructured":"West, E. E. et al. Loss of CD4+ T cell-intrinsic arginase 1 accelerates Th1 response kinetics and reduces lung pathology during influenza infection. Immunity 56, 2036\u20132053.e2012 (2023).","journal-title":"Immunity"},{"key":"2981_CR221","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s11427-020-1703-2","volume":"64","author":"G Yang","year":"2020","unstructured":"Yang, G., Xia, Y. & Ren, W. Glutamine metabolism in Th17\/Treg cell fate: applications in Th17 cell-associated diseases. Sci. China Life Sci. 64, 221\u2013233 (2020).","journal-title":"Sci. China Life Sci."},{"key":"2981_CR222","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00281-022-00959-z","volume":"44","author":"M Spiljar","year":"2022","unstructured":"Spiljar, M. & Kuchroo, V. K. Metabolic regulation and function of T helper cells in neuroinflammation. Semin. Immunopathol. 44, 581\u2013598 (2022).","journal-title":"Semin. Immunopathol."},{"key":"2981_CR223","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature23475","volume":"548","author":"T Xu","year":"2017","unstructured":"Xu, T. et al. Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism. Nature 548, 228\u2013233 (2017).","journal-title":"Nature"},{"key":"2981_CR224","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157418","volume":"148","author":"Y Liu","year":"2025","unstructured":"Liu, Y. et al. Celastrol attenuates Th17 cell response through downregulating HDAC3\/FOXO3\/GLS1-dependent glutaminolysis. Phytomedicine 148, 157418 (2025).","journal-title":"Phytomedicine"},{"key":"2981_CR225","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39571-6","volume":"14","author":"Q Zhou","year":"2023","unstructured":"Zhou, Q. et al. Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer. Nat. Commun. 14, 4677 (2023).","journal-title":"Nat. Commun."},{"key":"2981_CR226","doi-asserted-by":"publisher","first-page":"e02225","DOI":"10.1002\/advs.202502225","volume":"12","author":"T Ren","year":"2025","unstructured":"Ren, T. et al. Targeting glutamine metabolism transporter SLC25A22 enhances CD8+ T-cell function and anti-PD-1 therapy efficacy in cervical squamous cell carcinoma: integrated metabolomics, transcriptomics and T-cell-incorporated tumor organoid studies. Adv. Sci. 12, e02225 (2025).","journal-title":"Adv. Sci."},{"key":"2981_CR227","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107643","volume":"213","author":"Z Yuan","year":"2025","unstructured":"Yuan, Z. et al. Glutamine deprivation confers immunotherapy resistance by inhibiting IFN-\u03b3 signaling in cancer cells. Pharmacol. Res. 213, 107643 (2025).","journal-title":"Pharmacol. Res."},{"key":"2981_CR228","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/tri.12998","volume":"30","author":"GP Whitehouse","year":"2017","unstructured":"Whitehouse, G. P., Hope, A. & Sanchez-Fueyo, A. Regulatory T-cell therapy in liver transplantation. Transpl. Int. 30, 776\u2013784 (2017).","journal-title":"Transpl. Int."},{"key":"2981_CR229","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2024.102044","volume":"84","author":"L Zhang","year":"2024","unstructured":"Zhang, L. et al. Glutamine supplementation improves the activity and immunosuppressive action of induced regulatory T cells in vitro and in vivo. Transplant Immunol. 84, 102044 (2024).","journal-title":"Transplant Immunol."},{"key":"2981_CR230","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.697854","volume":"12","author":"W-w Guo","year":"2021","unstructured":"Guo, W. -w et al. Regulatory T cells in GVHD therapy. Front. Immunol. 12, 697854 (2021).","journal-title":"Front. Immunol."},{"key":"2981_CR231","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/j.clnu.2022.07.039","volume":"41","author":"LJ Miller","year":"2022","unstructured":"Miller, L. J. et al. Impact of enteral immunonutrition on infectious complications and immune and inflammatory markers in cancer patients undergoing chemotherapy: a systematic review of randomised controlled trials. Clin. Nutr. 41, 2135\u20132146 (2022).","journal-title":"Clin. Nutr."},{"key":"2981_CR232","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1420415","volume":"15","author":"X Ma","year":"2024","unstructured":"Ma, X. et al. Current research and future prospects of immunonutrition in gastrointestinal malignancies. Front. Immunol. 15, 1420415 (2024).","journal-title":"Front. Immunol."},{"key":"2981_CR233","doi-asserted-by":"publisher","first-page":"865102","DOI":"10.3389\/fnut.2022.865102","volume":"9","author":"S Dong","year":"2022","unstructured":"Dong, S. et al. Efficacy of glutamine in treating severe acute pancreatitis: a systematic review and meta-analysis. Front. Nutr. 9, 865102 (2022).","journal-title":"Front. Nutr."},{"key":"2981_CR234","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.clnu.2014.05.008","volume":"34","author":"T Jafari","year":"2015","unstructured":"Jafari, T., Feizi, A., Askari, G. & Fallah, A. A. Parenteral immunonutrition in patients with acute pancreatitis: a systematic review and meta-analysis. Clin. Nutr. 34, 35\u201343 (2015).","journal-title":"Clin. Nutr."},{"key":"2981_CR235","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-016-0220-y","volume":"6","author":"Z Hofman","year":"2016","unstructured":"Hofman, Z., Swinkels, S. & van Zanten, A. R. H. Glutamine, fish oil and antioxidants in critical illness: MetaPlus trial post hoc safety analysis. Ann. Intensive Care. 6, 119 (2016).","journal-title":"Ann. Intensive Care."},{"key":"2981_CR236","first-page":"CD007348","volume":"2016","author":"AK Akobeng","year":"2016","unstructured":"Akobeng, A. K., Elawad, M. & Gordon, M. Glutamine for induction of remission in Crohn\u2019s disease. Cochrane Database Syst. Rev. 2016, CD007348 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2981_CR237","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/nu18020208","volume":"18","author":"E Y\u0131lmaz Aky\u00fcz","year":"2026","unstructured":"Y\u0131lmaz Aky\u00fcz, E. et al. Therapeutic effect of arginine, glutamine and \u03b2-hydroxy \u03b2-methyl butyrate mixture as nutritional support on dss-induced ulcerative colitis in rats. Nutrients 18, 208 (2026).","journal-title":"Nutrients"},{"key":"2981_CR238","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s10787-021-00881-0","volume":"29","author":"M Mohajeri","year":"2021","unstructured":"Mohajeri, M., Horriatkhah, E. & Mohajery, R. The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case\u2013control study. Inflammopharmacology 29, 1769\u20131776 (2021).","journal-title":"Inflammopharmacology"},{"key":"2981_CR239","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1038\/s41418-021-00892-y","volume":"28","author":"T Matsuyama","year":"2021","unstructured":"Matsuyama, T., Yoshinaga, S. K., Shibue, K. & Mak, T. W. Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19. Cell Death Differ. 28, 3199\u20133213 (2021).","journal-title":"Cell Death Differ."},{"key":"2981_CR240","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/jdi.13497","volume":"12","author":"G Han","year":"2021","unstructured":"Han, G. et al. Glutamate is an essential mediator in glutamine-amplified insulin secretion. J. Diabetes Investig. 12, 920\u2013930 (2021).","journal-title":"J. Diabetes Investig."},{"key":"2981_CR241","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.2337\/db06-0868","volume":"55","author":"J-C Henquin","year":"2006","unstructured":"Henquin, J.-C., Dufrane, D. & Nenquin, M. Nutrient control of insulin secretion in isolated normal human islets. Diabetes 55, 3470\u20133477 (2006).","journal-title":"Diabetes"},{"key":"2981_CR242","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1093\/hmg\/ddx213","volume":"26","author":"M Grimaldi","year":"2017","unstructured":"Grimaldi, M. et al. Identification of the molecular dysfunction caused by glutamate dehydrogenase S445L mutation responsible for hyperinsulinism\/hyperammonemia. Hum. Mol. Genet. 26, 3453\u20133465 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"2981_CR243","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2019.04.013","volume":"491","author":"R Carlessi","year":"2019","unstructured":"Carlessi, R. et al. Glutamine deprivation induces metabolic adaptations associated with beta cell dysfunction and exacerbate lipotoxicity. Mol. Cell. Endocrinol. 491, 110433 (2019).","journal-title":"Mol. Cell. Endocrinol."},{"key":"2981_CR244","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/joim.20090","volume":"297","author":"D Rizo-Roca","year":"2025","unstructured":"Rizo-Roca, D., Henderson, J. D. & Zierath, J. R. Metabolomics in cardiometabolic diseases: key biomarkers and therapeutic implications for insulin resistance and diabetes. J. Intern. Med. 297, 584\u2013607 (2025).","journal-title":"J. Intern. Med."},{"key":"2981_CR245","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11154-025-09996-z","volume":"27","author":"P Carrera-Bastos","year":"2025","unstructured":"Carrera-Bastos, P. et al. Metabolic reprogramming in diabetes and other endocrine and metabolic disorders: exploring the Warburg effect, ketones, and SGLT2 inhibitors. Rev. Endocr. Metab. Disord. 27, 69\u201390 (2025).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"2981_CR246","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.2337\/db15-1063","volume":"65","author":"GA Walford","year":"2016","unstructured":"Walford, G. A. et al. Metabolite profiles of diabetes incidence and intervention response in the diabetes prevention program. Diabetes 65, 1424\u20131433 (2016).","journal-title":"Diabetes"},{"key":"2981_CR247","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2025.102208","volume":"99","author":"J Krawczyk","year":"2025","unstructured":"Krawczyk, J. et al. The diabetes gene Tcf7l2 organizes gene expression in the liver and regulates amino acid metabolism. Mol. Metab. 99, 102208 (2025).","journal-title":"Mol. Metab."},{"key":"2981_CR248","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3390\/nu11030536","volume":"11","author":"KY Abboud","year":"2019","unstructured":"Abboud, K. Y. et al. Oral glutamine supplementation reduces obesity, pro-inflammatory markers, and improves insulin sensitivity in DIO wistar rats and reduces waist circumference in overweight and obese humans. Nutrients 11, 536 (2019).","journal-title":"Nutrients"},{"key":"2981_CR249","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3945\/jn.111.139824","volume":"141","author":"D Samocha-Bonet","year":"2011","unstructured":"Samocha-Bonet, D. et al. Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients. J. Nutr. 141, 1233\u20131238 (2011).","journal-title":"J. Nutr."},{"key":"2981_CR250","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.2337\/db20-0475","volume":"69","author":"C Pipino","year":"2020","unstructured":"Pipino, C. et al. Association of the 1q25 diabetes-specific coronary heart disease locus with alterations of the \u03b3-glutamyl cycle and increased methylglyoxal levels in endothelial cells. Diabetes 69, 2206\u20132216 (2020).","journal-title":"Diabetes"},{"key":"2981_CR251","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.3390\/nu12103192","volume":"12","author":"C-L Yeh","year":"2020","unstructured":"Yeh, C.-L. et al. Intravenous glutamine administration improves glucose tolerance and attenuates the inflammatory response in diet-induced obese mice after sleeve gastrectomy. Nutrients 12, 3192 (2020).","journal-title":"Nutrients"},{"key":"2981_CR252","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2025.156357","volume":"172","author":"T Liang","year":"2025","unstructured":"Liang, T. et al. Lactiplantibacillus plantarum strain 84-3-derived l-glutamine ameliorates glucose homeostasis via AMPK\/PPAR\u03b3 signaling pathway activation in type 2 diabetes. Metabolism 172, 156357 (2025).","journal-title":"Metabolism"},{"key":"2981_CR253","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.1001419","volume":"9","author":"A Kordowski","year":"2022","unstructured":"Kordowski, A. et al. A nutritional supplement based on a synbiotic combination of Bacillus subtilis DSM 32315 and L-alanyl-L-glutamine improves glucose metabolism in healthy prediabetic subjects\u2014a real-life post-marketing study. Front. Nutr. 9, 1001419 (2022).","journal-title":"Front. Nutr."},{"key":"2981_CR254","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101750","volume":"74","author":"C Forteath","year":"2023","unstructured":"Forteath, C. et al. Amino acid homeostasis is a target of metformin therapy. Mol. Metab. 74, 101750 (2023).","journal-title":"Mol. Metab."},{"key":"2981_CR255","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0273-y","volume":"9","author":"PF Secker","year":"2018","unstructured":"Secker, P. F. et al. Canagliflozin mediated dual inhibition of mitochondrial glutamate dehydrogenase and complex I: an off-target adverse effect. Cell Death Dis. 9, 226 (2018).","journal-title":"Cell Death Dis."},{"key":"2981_CR256","volume":"2020","author":"ZEH Moore","year":"2020","unstructured":"Moore, Z. E. H., Corcoran, M. A. & Patton, D. Nutritional interventions for treating foot ulcers in people with diabetes. Cochrane Database Syst. Rev. 2020, CD011378 (2020).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2981_CR257","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","volume":"9","author":"CB Newgard","year":"2009","unstructured":"Newgard, C. B. et al. A Branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9, 311\u2013326 (2009).","journal-title":"Cell Metab"},{"key":"2981_CR258","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.apsb.2024.07.023","volume":"15","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. l-[5-11C]Glutamine PET imaging noninvasively tracks dynamic responses of glutaminolysis in non-alcoholic steatohepatitis. Acta Pharm. Sin. B. 15, 681\u2013691 (2025).","journal-title":"Acta Pharm. Sin. B."},{"key":"2981_CR259","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcmgh.2019.12.006","volume":"10","author":"K Du","year":"2020","unstructured":"Du, K. et al. Increased glutaminolysis marks active scarring in nonalcoholic steatohepatitis progression. Cell. Mol. Gastroenterol. Hepatol. 10, 1\u201321 (2020).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"2981_CR260","doi-asserted-by":"publisher","first-page":"E1326","DOI":"10.1152\/ajpendo.90921.2008","volume":"296","author":"H Kobayashi","year":"2009","unstructured":"Kobayashi, H. et al. Dysregulated glutathione metabolism links to impaired insulin action in adipocytes. Am. J. Physiol. Endocrinol. Metab. 296, E1326\u2013E1334 (2009).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2981_CR261","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.clnu.2015.01.021","volume":"35","author":"P Jegatheesan","year":"2016","unstructured":"Jegatheesan, P. et al. Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease. Clin. Nutr. 35, 175\u2013182 (2016).","journal-title":"Clin. Nutr."},{"key":"2981_CR262","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102732","volume":"63","author":"Y Kong","year":"2023","unstructured":"Kong, Y. et al. Lipophagy-mediated cholesterol synthesis inhibition is required for the survival of hepatocellular carcinoma under glutamine deprivation. Redox Biol. 63, 102732 (2023).","journal-title":"Redox Biol."},{"key":"2981_CR263","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2026.118448","volume":"228","author":"K Chen","year":"2026","unstructured":"Chen, K. et al. Lacto-N-triose II alleviates metabolic dysfunction-associated Steatotic liver disease via microbiota-dependent citrulline biosynthesis. Food Res. Int. 228, 118448 (2026).","journal-title":"Food Res. Int."},{"key":"2981_CR264","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.3390\/nu17132228","volume":"17","author":"J Shen","year":"2025","unstructured":"Shen, J. et al. Integrated multi-omics analysis reveals the regulatory mechanism of peanut skin procyanidins on lipid metabolism in high-fat-diet-induced obese mice. Nutrients 17, 2228 (2025).","journal-title":"Nutrients"},{"key":"2981_CR265","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","volume":"15","author":"A Tripathi","year":"2018","unstructured":"Tripathi, A. et al. The gut\u2013liver axis and the intersection with the microbiome. Nat. Rev. Gastroenterol. Hepatol. 15, 397\u2013411 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2981_CR266","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/s41586-025-08778-6","volume":"641","author":"MdM Rigual","year":"2025","unstructured":"Rigual, M.dM. et al. Macrophages harness hepatocyte glutamate to boost liver regeneration. Nature 641, 1005\u20131016 (2025).","journal-title":"Nature"},{"key":"2981_CR267","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.clnu.2025.09.018","volume":"54","author":"M Dzubanova","year":"2025","unstructured":"Dzubanova, M. et al. Glutamine: a novel player in maintaining skeletal strength and body fitness in obese mice. Clin. Nutr. 54, 162\u2013176 (2025).","journal-title":"Clin. Nutr."},{"key":"2981_CR268","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003755","volume":"5","author":"Y Zheng","year":"2016","unstructured":"Zheng, Y. et al. Metabolites of glutamate metabolism are associated with incident cardiovascular events in the PREDIMED PREvenci\u00f3n con DIeta MEDiterr\u00e1nea (PREDIMED) trial. J. Am. Heart Assoc. 5, e003755 (2016).","journal-title":"J. Am. Heart Assoc."},{"key":"2981_CR269","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/ije\/dyx234","volume":"47","author":"W Ma","year":"2018","unstructured":"Ma, W. et al. Dietary glutamine, glutamate and mortality: two large prospective studies in US men and women. Int. J. Epidemiol. 47, 311\u2013320 (2018).","journal-title":"Int. J. Epidemiol."},{"key":"2981_CR270","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.3390\/antiox10091369","volume":"10","author":"A Santiago-Hernandez","year":"2021","unstructured":"Santiago-Hernandez, A. et al. Metabolic alterations identified in urine, plasma and aortic smooth muscle cells reflect cardiovascular risk in patients with programmed coronary artery bypass grafting. Antioxidants 10, 1369 (2021).","journal-title":"Antioxidants"},{"key":"2981_CR271","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.3390\/ijms22115602","volume":"22","author":"HY Park","year":"2021","unstructured":"Park, H. Y. et al. Inhibitory effect of a glutamine antagonist on proliferation and migration of VSMCs via simultaneous attenuation of glycolysis and oxidative phosphorylation. Int. J. Mol. Sci. 22, 5602 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"2981_CR272","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1021\/acs.jmedchem.8b00327","volume":"62","author":"SC Zimmermann","year":"2018","unstructured":"Zimmermann, S. C., Duvall, B. & Tsukamoto, T. Recent progress in the discovery of allosteric inhibitors of kidney-type glutaminase. J. Med. Chem. 62, 46\u201359 (2018).","journal-title":"J. Med. Chem."},{"key":"2981_CR273","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.cmet.2024.04.010","volume":"36","author":"NS Rachedi","year":"2024","unstructured":"Rachedi, N. S. et al. Dietary intake and glutamine-serine metabolism control pathologic vascular stiffness. Cell Metab. 36, 1335\u20131350.e1338 (2024).","journal-title":"Cell Metab."},{"key":"2981_CR274","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1089\/ars.2024.0741","volume":"43","author":"J Abe","year":"2025","unstructured":"Abe, J. et al. Impacts of radiation on metabolism and vascular cell senescence. Antioxid. Redox Signal. 43, 92\u2013114 (2025).","journal-title":"Antioxid. Redox Signal."},{"key":"2981_CR275","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s44318-025-00642-7","volume":"45","author":"N Herrle","year":"2025","unstructured":"Herrle, N. et al. The transaminase-\u03c9-amidase pathway senses oxidative stress to control glutamine metabolism and \u03b1-ketoglutarate levels in endothelial cells. EMBO J. 45, 820\u2013855 (2025).","journal-title":"EMBO J."},{"key":"2981_CR276","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/antiox12010071","volume":"12","author":"ER DeVallance","year":"2022","unstructured":"DeVallance, E. R. et al. Specificity protein 1-mediated promotion of CXCL12 advances endothelial cell metabolism and proliferation in pulmonary hypertension. Antioxidants 12, 71 (2022).","journal-title":"Antioxidants"},{"key":"2981_CR277","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1089\/dna.2019.5034","volume":"39","author":"J Chen","year":"2020","unstructured":"Chen, J. et al. Essential role of nonessential amino acid glutamine in atherosclerotic cardiovascular disease. DNA Cell Biol. 39, 8\u201315 (2020).","journal-title":"DNA Cell Biol."},{"key":"2981_CR278","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1038\/s44161-024-00566-1","volume":"3","author":"F Murcy","year":"2024","unstructured":"Murcy, F. et al. GLS2 links glutamine metabolism and atherosclerosis by remodeling artery walls. Nat. Cardiovasc. Res. 3, 1454\u20131467 (2024).","journal-title":"Nat. Cardiovasc. Res."},{"key":"2981_CR279","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202414252","volume":"12","author":"Z Zhou","year":"2025","unstructured":"Zhou, Z. et al. GLS1-mediated redundancy in glutamate accelerates arterial calcification via activating NMDAR\/Ca2+\/\u03b2-catenin pathway. Adv. Sci. 12, 2414252 (2025).","journal-title":"Adv. Sci."},{"key":"2981_CR280","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1093\/cvr\/cvaf210","volume":"121","author":"T \u00d6rd","year":"2025","unstructured":"\u00d6rd, T. et al. Single-cell to pre-clinical evaluation of Trem2, Folr2, and Slc7a7 as macrophage-associated biomarkers for atherosclerosis. Cardiovasc. Res. 121, 2503\u20132519 (2025).","journal-title":"Cardiovasc. Res."},{"key":"2981_CR281","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2024.104764","volume":"158","author":"A Kawakami","year":"2025","unstructured":"Kawakami, A. et al. Cardioprotective effects of l-glutamine in an ischemic rat heart model. Microvasc. Res. 158, 104764 (2025).","journal-title":"Microvasc. Res."},{"key":"2981_CR282","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05645-y","volume":"14","author":"M Tan","year":"2023","unstructured":"Tan, M. et al. Glutathione system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis. Cell Death Dis. 14, 131 (2023).","journal-title":"Cell Death Dis."},{"key":"2981_CR283","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2022.107517","volume":"169","author":"X Wan","year":"2022","unstructured":"Wan, X. et al. Metabolomics strategy comprehensively unveils the effect of catechins intervention on the biomarkers of exposure to acrylamide and biomarkers of cardiometabolic risk. Environ. Int. 169, 107517 (2022).","journal-title":"Environ. Int."},{"key":"2981_CR284","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41569-021-00610-8","volume":"18","author":"KD O\u2019Brien","year":"2021","unstructured":"O\u2019Brien, K. D. & Tian, R. Boosting mitochondrial metabolism with dietary supplements in heart failure. Nat. Rev. Cardiol. 18, 685\u2013686 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"2981_CR285","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/cns.13184","volume":"25","author":"LL Luo","year":"2019","unstructured":"Luo, L. L. et al. L-glutamine protects mouse brain from ischemic injury via up-regulating heat shock protein 70. CNS Neurosci. Ther. 25, 1030\u20131041 (2019).","journal-title":"CNS Neurosci. Ther."},{"key":"2981_CR286","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.028022","volume":"12","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Metabolomic profiles, ideal cardiovascular health, and risk of heart failure and atrial fibrillation: insights From the Framingham Heart Study. J. Am. Heart Assoc. 12, e028022 (2023).","journal-title":"J. Am. Heart Assoc."},{"key":"2981_CR287","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1161\/CIRCHEARTFAILURE.115.002073","volume":"8","author":"C Wu","year":"2015","unstructured":"Wu, C. et al. Supplementation of l-alanyl-l-glutamine and fish oil improves body composition and quality of life in patients with chronic heart failure. Circ. Heart Fail. 8, 1077\u20131087 (2015).","journal-title":"Circ. Heart Fail."},{"key":"2981_CR288","doi-asserted-by":"publisher","first-page":"e2344546","DOI":"10.1001\/jamanetworkopen.2023.44546","volume":"6","author":"TV Newman","year":"2023","unstructured":"Newman, T. V. et al. Use of disease-modifying treatments in patients with sickle cell disease. JAMA Netw. Open. 6, e2344546 (2023).","journal-title":"JAMA Netw. Open."},{"key":"2981_CR289","doi-asserted-by":"publisher","first-page":"100351","DOI":"10.1016\/j.modpat.2023.100351","volume":"37","author":"P Jafari","year":"2024","unstructured":"Jafari, P. et al. Portosinusoidal vascular disorder: a heretofore unrecognized manifestation of sickle cell disease?. Mod. Pathol. 37, 100351 (2024).","journal-title":"Mod. Pathol."},{"key":"2981_CR290","doi-asserted-by":"crossref","unstructured":"Geng, H.-R. et al. Gestational low carbamoyl phosphate suppresses TET2-mediated DNA demethylation and induces congenital heart disease in offspring. J. Adv. Res., S2090123226001530 (2026).","DOI":"10.1016\/j.jare.2026.02.021"},{"key":"2981_CR291","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-71856-4","volume":"17","author":"P Yang","year":"2026","unstructured":"Yang, P. et al. SLC1A5 prevents aortic aneurysm and dissection by glutaminolytic-epigenetic orchestration of vascular smooth muscle cell homeostasis. Nat. Commun. 17, 6555 (2026).","journal-title":"Nat. Commun."},{"key":"2981_CR292","doi-asserted-by":"publisher","DOI":"10.1172\/JCI148556","volume":"132","author":"NE Boutagy","year":"2022","unstructured":"Boutagy, N. E., Singh, A. K. & Sessa, W. C. Targeting the vasculature in cardiometabolic disease. J. Clin. Investig. 132, e148556 (2022).","journal-title":"J. Clin. Investig."},{"key":"2981_CR293","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cmet.2011.07.015","volume":"14","author":"KE Bornfeldt","year":"2011","unstructured":"Bornfeldt, K. E. & Tabas, I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab 14, 575\u2013585 (2011).","journal-title":"Cell Metab"},{"key":"2981_CR294","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.3390\/nu12092509","volume":"12","author":"V Cassano","year":"2020","unstructured":"Cassano, V. et al. Uric acid and vascular damage in essential hypertension: role of insulin resistance. Nutrients 12, 2509 (2020).","journal-title":"Nutrients"},{"key":"2981_CR295","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.apsb.2019.10.007","volume":"10","author":"L Pan","year":"2020","unstructured":"Pan, L. et al. Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia. Acta Pharm. Sin. B. 10, 249\u2013261 (2020).","journal-title":"Acta Pharm. Sin. B."},{"key":"2981_CR296","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","volume":"65","author":"M Parola","year":"2019","unstructured":"Parola, M. & Pinzani, M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol. Aspects Med. 65, 37\u201355 (2019).","journal-title":"Mol. Aspects Med."},{"key":"2981_CR297","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1055\/s-2007-991517","volume":"27","author":"J Guo","year":"2007","unstructured":"Guo, J. & Friedman, S. L. Hepatic fibrogenesis. Semin. Liver Dis. 27, 413\u2013426 (2007).","journal-title":"Semin. Liver Dis."},{"key":"2981_CR298","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","volume":"158","author":"RF Schwabe","year":"2020","unstructured":"Schwabe, R. F., Tabas, I. & Pajvani, U. B. Mechanisms of fibrosis development in nonalcoholic steatohepatitis. Gastroenterology 158, 1913\u20131928 (2020).","journal-title":"Gastroenterology"},{"key":"2981_CR299","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2025.102132","volume":"96","author":"R Huang","year":"2025","unstructured":"Huang, R. et al. LOX-1 rewires glutamine ammonia metabolism to drive liver fibrosis. Mol. Metab. 96, 102132 (2025).","journal-title":"Mol. Metab."},{"key":"2981_CR300","doi-asserted-by":"publisher","first-page":"27953","DOI":"10.1021\/acs.jafc.4c08211","volume":"72","author":"L Li","year":"2024","unstructured":"Li, L. et al. Lactate dehydrogenase inhibition protects against hepatic fibrosis by regulating metabolic reprogramming of hepatic stellate cells. J. Agric. Food Chem. 72, 27953\u201327964 (2024).","journal-title":"J. Agric. Food Chem."},{"key":"2981_CR301","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1186\/s13287-022-03049-x","volume":"13","author":"B Wu","year":"2022","unstructured":"Wu, B. et al. ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis. Stem Cell. Res. Ther. 13, 494 (2022).","journal-title":"Stem Cell. Res. Ther."},{"key":"2981_CR302","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.jhep.2016.07.040","volume":"65","author":"S Dasarathy","year":"2016","unstructured":"Dasarathy, S. & Merli, M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J. Hepatol. 65, 1232\u20131244 (2016).","journal-title":"J. Hepatol."},{"key":"2981_CR303","doi-asserted-by":"publisher","DOI":"10.1172\/JCI186478","volume":"135","author":"Y Fu","year":"2025","unstructured":"Fu, Y. et al. Disrupted minor intron splicing activates reductive carboxylation-mediated lipogenesis to drive metabolic dysfunction\u2013associated steatotic liver disease progression. J. Clin. Investig. 135, e186478 (2025).","journal-title":"J. Clin. Investig."},{"key":"2981_CR304","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.chom.2024.06.008","volume":"32","author":"H Shen","year":"2024","unstructured":"Shen, H. et al. Dietary fiber alleviates alcoholic liver injury via Bacteroides acidifaciens and subsequent ammonia detoxification. Cell Host Microbe 32, 1331\u20131346.e1336 (2024).","journal-title":"Cell Host Microbe"},{"key":"2981_CR305","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46481-8","volume":"15","author":"D Evstafeva","year":"2024","unstructured":"Evstafeva, D. et al. Inhibition of urease-mediated ammonia production by 2-octynohydroxamic acid in hepatic encephalopathy. Nat. Commun. 15, 2226 (2024).","journal-title":"Nat. Commun."},{"key":"2981_CR306","volume":"10","author":"T Chen","year":"2026","unstructured":"Chen, T. et al. Shared signatures of alcohol-associated dysbiosis in humans and non-human primates. Curr. Res. Microb. Sci. 10, 100534 (2026).","journal-title":"Curr. Res. Microb. Sci."},{"key":"2981_CR307","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41420-025-02715-2","volume":"11","author":"H Zheng","year":"2025","unstructured":"Zheng, H. et al. Metabolic dysregulation in pulmonary fibrosis: insights into amino acid contributions and therapeutic potential. Cell Death Discov. 11, 411 (2025).","journal-title":"Cell Death Discov."},{"key":"2981_CR308","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413017","volume":"12","author":"M Chen","year":"2025","unstructured":"Chen, M. et al. Cathepsin K aggravates pulmonary fibrosis through promoting fibroblast glutamine metabolism and collagen synthesis. Adv. Sci. 12, e13017 (2025).","journal-title":"Adv. Sci."},{"key":"2981_CR309","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101655","volume":"67","author":"Z Xiang","year":"2023","unstructured":"Xiang, Z. et al. Epigenetic regulation of IPF fibroblast phenotype by glutaminolysis. Mol. Metab. 67, 101655 (2023).","journal-title":"Mol. Metab."},{"key":"2981_CR310","doi-asserted-by":"publisher","first-page":"987","DOI":"10.7150\/ijbs.89960","volume":"20","author":"Y Cai","year":"2024","unstructured":"Cai, Y. et al. Glutamine metabolism promotes renal fibrosis through regulation of mitochondrial energy generation and mitochondrial fission. Int. J. Biol. Sci. 20, 987\u20131003 (2024).","journal-title":"Int. J. Biol. Sci."},{"key":"2981_CR311","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-026-01328-w","volume":"21","author":"R-r Gao","year":"2026","unstructured":"Gao, R. -r, Han, C. & Li, W. Fatty acid metabolism: opportunities and challenges of traditional Chinese medicine in the treatment of renal fibrosis. Chin. Med. 21, 45 (2026).","journal-title":"Chin. Med."},{"key":"2981_CR312","doi-asserted-by":"publisher","first-page":"76","DOI":"10.7555\/JBR.39.20250162","volume":"40","author":"J Ni","year":"2026","unstructured":"Ni, J. et al. Probiotic Akkermansia muciniphila alleviates acute kidney injury by protecting the intestinal barrier and modulating gut microbiota and metabolites. J. Biomed. Res. 40, 76\u201388 (2026).","journal-title":"J. Biomed. Res."},{"key":"2981_CR313","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1093\/ndt\/gfx349","volume":"33","author":"I Soomro","year":"2018","unstructured":"Soomro, I. et al. Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease. Nephrol. Dial. Transplant. 33, 1343\u20131353 (2018).","journal-title":"Nephrol. Dial. Transplant."},{"key":"2981_CR314","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s42003-018-0200-x","volume":"1","author":"C Podrini","year":"2018","unstructured":"Podrini, C. et al. Dissection of metabolic reprogramming in polycystic kidney disease reveals coordinated rewiring of bioenergetic pathways. Commun. Biol. 1, 194 (2018).","journal-title":"Commun. Biol."},{"key":"2981_CR315","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s44321-024-00071-9","volume":"16","author":"S Clerici","year":"2024","unstructured":"Clerici, S. et al. Inhibition of asparagine synthetase effectively retards polycystic kidney disease progression. EMBO Mol. Med. 16, 1379\u20131403 (2024).","journal-title":"EMBO Mol. Med."},{"key":"2981_CR316","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03036-y","volume":"9","author":"EM Flowers","year":"2018","unstructured":"Flowers, E. M. et al. Lkb1 deficiency confers glutamine dependency in polycystic kidney disease. Nat. Commun. 9, 814 (2018).","journal-title":"Nat. Commun."},{"key":"2981_CR317","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.kint.2018.08.031","volume":"94","author":"A Vychytil","year":"2018","unstructured":"Vychytil, A. et al. A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health. Kidney Int. 94, 1227\u20131237 (2018).","journal-title":"Kidney Int."},{"key":"2981_CR318","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3390\/nu12020402","volume":"12","author":"R Blaauw","year":"2020","unstructured":"Blaauw, R., Nel, D. G. & Schleicher, G. K. Plasma glutamine levels in relation to intensive care unit patient outcome. Nutrients 12, 402 (2020).","journal-title":"Nutrients"},{"key":"2981_CR319","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202102038","volume":"11","author":"LP Zhao","year":"2021","unstructured":"Zhao, L. P. et al. Self-delivery nanomedicine for glutamine-starvation enhanced photodynamic tumor therapy. Adv. Healthc. Mater. 11, 2102038 (2021).","journal-title":"Adv. Healthc. Mater."},{"key":"2981_CR320","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1039\/D0FO03080E","volume":"12","author":"B Xu","year":"2021","unstructured":"Xu, B. et al. Dietary glycyl-glutamine supplementation ameliorates intestinal integrity, inflammatory response, and oxidative status in association with the gut microbiota in LPS-challenged piglets. Food Funct. 12, 3539\u20133551 (2021).","journal-title":"Food Funct."},{"key":"2981_CR321","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2023.122684","volume":"338","author":"R Zhang","year":"2023","unstructured":"Zhang, R. et al. Perfluorooctanoic acid-induced metabolic disorder via enhancing metabolism of glutamine and fatty acids in human intestinal cells. Environ. Pollut. 338, 122684 (2023).","journal-title":"Environ. Pollut."},{"key":"2981_CR322","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3748\/wjg.v24.i5.583","volume":"24","author":"Y-Y Xu","year":"2018","unstructured":"Xu, Y.-Y. et al. Enteral nutrition combined with glutamine promotes recovery after ileal pouch-anal anastomosis in rats. World J. Gastroenterol. 24, 583\u2013592 (2018).","journal-title":"World J. Gastroenterol."},{"key":"2981_CR323","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1021\/acs.jafc.3c08701","volume":"72","author":"Y-X Fang","year":"2024","unstructured":"Fang, Y.-X. et al. Glutamine promotes porcine intestinal epithelial cell proliferation through the Wnt\/\u03b2-catenin pathway. J. Agric. Food Chem. 72, 7155\u20137166 (2024).","journal-title":"J. Agric. Food Chem."},{"key":"2981_CR324","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41575-022-00675-x","volume":"19","author":"JK Gustafsson","year":"2022","unstructured":"Gustafsson, J. K. & Johansson, M. E. V. The role of goblet cells and mucus in intestinal homeostasis. Nat. Rev. Gastroenterol. Hepatol. 19, 785\u2013803 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2981_CR325","doi-asserted-by":"publisher","first-page":"9250189","DOI":"10.26599\/FSHW.2024.9250189","volume":"14","author":"Y Pan","year":"2025","unstructured":"Pan, Y. et al. Study on the mechanism of glutamine promoting the synthesis of colonic mucin and maintaining the stability of intestinal microbiota in septic mice. Food Sci. Hum. Wellness. 14, 9250189 (2025).","journal-title":"Food Sci. Hum. Wellness."},{"key":"2981_CR326","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1136\/gutjnl-2017-315136","volume":"68","author":"Q Zhou","year":"2019","unstructured":"Zhou, Q. et al. Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome. Gut 68, 996\u20131002 (2019).","journal-title":"Gut"},{"key":"2981_CR327","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0261-5614(03)00040-2","volume":"22","author":"M Co\u00ebffier","year":"2003","unstructured":"Co\u00ebffier, M. Modulating effect of glutamine on IL-1\u03b2-induced cytokine production by human gut. Clin. Nutr. 22, 407\u2013413 (2003).","journal-title":"Clin. Nutr."},{"key":"2981_CR328","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1056\/NEJMoa2513654","volume":"394","author":"N Gharahdaghi","year":"2026","unstructured":"Gharahdaghi, N. et al. Interleukin-10 autoantibodies and HLA-DRB1*01:03 in inflammatory bowel disease. N. Engl. J. Med. 394, 2212\u20132222 (2026).","journal-title":"N. Engl. J. Med."},{"key":"2981_CR329","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s10753-016-0424-1","volume":"39","author":"ACA Santos","year":"2016","unstructured":"Santos, A. C. A. et al. Intravenous glutamine administration modulates TNF-\u03b1\/IL-10 ratio and attenuates NFkB phosphorylation in a protein malnutrition model. Inflammation 39, 1883\u20131891 (2016).","journal-title":"Inflammation"},{"key":"2981_CR330","doi-asserted-by":"publisher","first-page":"5049","DOI":"10.3390\/nu15245049","volume":"15","author":"FM Pavel","year":"2023","unstructured":"Pavel, F. M. et al. Clinical implications of dietary probiotic supplement (associated with L-glutamine and biotin) in ulcerative colitis patients\u2019 body composition and quality of life. Nutrients 15, 5049 (2023).","journal-title":"Nutrients"},{"key":"2981_CR331","doi-asserted-by":"publisher","first-page":"1614782","DOI":"10.3389\/fnut.2025.1614782","volume":"12","author":"M Huang","year":"2025","unstructured":"Huang, M. et al. Oral low dose of glutamine improved the spontaneous closure in patients with external duodenal fistula: a retrospective comparative study with propensity score matching. Front. Nutr. 12, 1614782 (2025).","journal-title":"Front. Nutr."},{"key":"2981_CR332","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110832","volume":"124","author":"S Li","year":"2023","unstructured":"Li, S. et al. Glutamine protects intestinal immunity through microbial metabolites rather than microbiota. Int. Immunopharmacol. 124, 110832 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"2981_CR333","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nm.4358","volume":"23","author":"R Liu","year":"2017","unstructured":"Liu, R. et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat. Med. 23, 859\u2013868 (2017).","journal-title":"Nat. Med."},{"key":"2981_CR334","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.nut.2015.01.004","volume":"31","author":"AZ Zambom de Souza","year":"2015","unstructured":"Zambom de Souza, A. Z. et al. Oral supplementation with l-glutamine alters gut microbiota of obese and overweight adults: a pilot study. Nutrition 31, 884\u2013889 (2015).","journal-title":"Nutrition"},{"key":"2981_CR335","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1136\/gutjnl-2019-319766","volume":"69","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents. Gut 69, 2131\u20132142 (2020).","journal-title":"Gut"},{"key":"2981_CR336","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1101\/gad.312355.118","volume":"32","author":"VL Nelson","year":"2018","unstructured":"Nelson, V. L. et al. PPAR\u03b3 is a nexus controlling alternative activation of macrophages via glutamine metabolism. Genes Dev. 32, 1035\u20131044 (2018).","journal-title":"Genes Dev."},{"key":"2981_CR337","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","volume":"136","author":"P Nicklin","year":"2009","unstructured":"Nicklin, P. et al. Bidirectional transport of amino acids regulates mtor and autophagy. Cell 136, 521\u2013534 (2009).","journal-title":"Cell"},{"key":"2981_CR338","doi-asserted-by":"publisher","first-page":"2614115","DOI":"10.1080\/19490976.2026.2614115","volume":"18","author":"Y Li","year":"2026","unstructured":"Li, Y. et al. Probiotic extracellular vesicles reprogram macrophage immunometabolism: From gut crosstalk to host health. Gut Microbes 18, 2614115 (2026).","journal-title":"Gut Microbes"},{"key":"2981_CR339","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202500548","volume":"15","author":"CL D\u2019Antoni","year":"2025","unstructured":"D\u2019Antoni, C. L. et al. Membrane vesicles from Lacticaseibacillus Casei BL23 exhibit antimicrobial activity against Escherichia coli and immunostimulatory effects on human peripheral blood mononuclear cells. Adv. Healthc. Mater. 15, e00548 (2025).","journal-title":"Adv. Healthc. Mater."},{"key":"2981_CR340","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/SHK.0000000000001593","volume":"55","author":"Y Leng","year":"2021","unstructured":"Leng, Y. et al. Prevention of severe intestinal barrier dysfunction through a single-species probiotics is associated with the activation of microbiome-mediated glutamate\u2013glutamine biosynthesis. Shock 55, 128\u2013137 (2021).","journal-title":"Shock"},{"key":"2981_CR341","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s00726-014-1793-0","volume":"46","author":"W Ren","year":"2014","unstructured":"Ren, W. et al. Dietary l-glutamine supplementation modulates microbial community and activates innate immunity in the mouse intestine. Amino Acids 46, 2403\u20132413 (2014).","journal-title":"Amino Acids"},{"key":"2981_CR342","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00726-012-1264-4","volume":"45","author":"Z-L Dai","year":"2012","unstructured":"Dai, Z.-L. et al. l-Glutamine regulates amino acid utilization by intestinal bacteria. Amino Acids 45, 501\u2013512 (2012).","journal-title":"Amino Acids"},{"key":"2981_CR343","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.chom.2024.04.004","volume":"32","author":"T-T Li","year":"2024","unstructured":"Li, T.-T. et al. Microbiota metabolism of intestinal amino acids impacts host nutrient homeostasis and physiology. Cell Host Microbe 32, 661\u2013675.e610 (2024).","journal-title":"Cell Host Microbe"},{"key":"2981_CR344","doi-asserted-by":"publisher","first-page":"1155620","DOI":"10.3389\/fnmol.2023.1155620","volume":"16","author":"T Pate","year":"2023","unstructured":"Pate, T., Anthony, D. C. & Radford-Smith, D. E. cFOS expression in the prefrontal cortex correlates with altered cerebral metabolism in developing germ-free mice. Front. Mol. Neurosci. 16, 1155620 (2023).","journal-title":"Front. Mol. Neurosci."},{"key":"2981_CR345","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jss.2023.11.041","volume":"295","author":"RE Akhigbe","year":"2024","unstructured":"Akhigbe, R. E., Adedamola Aminat, B.-O., Akhigbe, T. M. & Hamed, M. A. Glutamine alleviates I\/R-induced intestinal injury and dysmotility via the downregulation of xanthine oxidase\/uric acid signaling and lactate generation in wistar rats. J. Surg. Res. 295, 431\u2013441 (2024).","journal-title":"J. Surg. Res."},{"key":"2981_CR346","doi-asserted-by":"publisher","first-page":"324","DOI":"10.5009\/gnl.2014.8.3.324","volume":"8","author":"R-Y Xu","year":"2014","unstructured":"Xu, R.-Y. et al. Glutamine-supplemented parenteral nutrition and probiotics in four adult autoimmune enteropathy patients. Gut Liver 8, 324\u2013328 (2014).","journal-title":"Gut Liver"},{"key":"2981_CR347","first-page":"253","volume":"29","author":"X Jiang","year":"2020","unstructured":"Jiang, X. et al. Glutamine supported early enteral therapy for severe acute pancreatitis: a systematic review and meta-analysis. Asia Pac. J. Clin. Nutr. 29, 253\u2013261 (2020).","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"2981_CR348","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1042\/CS20030251","volume":"106","author":"IS Falc\u00c3O De Arruda","year":"2004","unstructured":"Falc\u00c3O De Arruda, I. S. & De Aguilar-Nascimento, J. E. Benefits of early enteral nutrition with glutamine and probiotics in brain injury patients. Clin. Sci. 106, 287\u2013292 (2004).","journal-title":"Clin. Sci."},{"key":"2981_CR349","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-025-03743-3","volume":"16","author":"X Liu","year":"2025","unstructured":"Liu, X. et al. Alterations in short-chain fatty acid-associated gut microbiota and tight junction integrity in adolescent major depressive disorder. Transl. Psychiatry 16, 11 (2025).","journal-title":"Transl. Psychiatry"},{"key":"2981_CR350","doi-asserted-by":"crossref","unstructured":"Zhou, N.-N. et al. Cetobacterium somerae ZNN-1 promotes goblet cell differentiation through glutamine-mediated notch signaling suppression. J. Adv. Res., S2090123225010367 (2025).","DOI":"10.1016\/j.jare.2025.12.046"},{"key":"2981_CR351","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.2147\/DDDT.S458983","volume":"18","author":"L Tang","year":"2024","unstructured":"Tang, L. et al. Microbiome metabolomic analysis of the anxiolytic effect of baihe dihuang decoction in a rat model of chronic restraint stress. Drug Des. Dev. Ther. 18, 2227\u20132248 (2024).","journal-title":"Drug Des. Dev. Ther."},{"key":"2981_CR352","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1016\/j.clnu.2018.09.029","volume":"38","author":"S Kartaram","year":"2019","unstructured":"Kartaram, S. et al. Plasma citrulline concentration, a marker for intestinal functionality, reflects exercise intensity in healthy young men. Clin. Nutr. 38, 2251\u20132258 (2019).","journal-title":"Clin. Nutr."},{"key":"2981_CR353","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1007\/s11064-022-03771-1","volume":"48","author":"JV Andersen","year":"2022","unstructured":"Andersen, J. V. & Schousboe, A. Glial glutamine homeostasis in health and disease. Neurochem. Res. 48, 1100\u20131128 (2022).","journal-title":"Neurochem. Res."},{"key":"2981_CR354","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14617","volume":"30","author":"D Zhang","year":"2024","unstructured":"Zhang, D., Hua, Z. & Li, Z. The role of glutamate and glutamine metabolism and related transporters in nerve cells. CNS Neurosci. Ther. 30, e14617 (2024).","journal-title":"CNS Neurosci. Ther."},{"key":"2981_CR355","doi-asserted-by":"publisher","first-page":"102331","DOI":"10.1016\/j.pneurobio.2022.102331","volume":"217","author":"JV Andersen","year":"2022","unstructured":"Andersen, J. V., Schousboe, A. & Verkhratsky, A. Astrocyte energy and neurotransmitter metabolism in Alzheimer\u2019s disease: Integration of the glutamate\/GABA-glutamine cycle. Prog. Neurobiol. 217, 102331 (2022).","journal-title":"Prog. Neurobiol."},{"key":"2981_CR356","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1042\/EBC20220208","volume":"67","author":"JP Bola\u00f1os","year":"2023","unstructured":"Bola\u00f1os, J. P., Andersen, J. V., Schousboe, A. & Wellendorph, P. Astrocytes regulate inhibitory neurotransmission through GABA uptake, metabolism, and recycling. Essays Biochem. 67, 77\u201391 (2023).","journal-title":"Essays Biochem."},{"key":"2981_CR357","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1002\/glia.23872","volume":"68","author":"JV Andersen","year":"2020","unstructured":"Andersen, J. V. et al. Extensive astrocyte metabolism of \u03b3-aminobutyric acid (GABA) sustains glutamine synthesis in the mammalian cerebral cortex. Glia 68, 2601\u20132612 (2020).","journal-title":"Glia"},{"key":"2981_CR358","doi-asserted-by":"crossref","unstructured":"Radzishevsky, I. et al. SLC38A3 deficiency reveals a critical role of blood-derived glutamine in brain development. Brain 149, 2747\u20132759 (2025).","DOI":"10.1093\/brain\/awaf473"},{"key":"2981_CR359","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/jnc.15811","volume":"166","author":"JV Andersen","year":"2023","unstructured":"Andersen, J. V. & Schousboe, A. Milestone Review: metabolic dynamics of glutamate and GABA mediated neurotransmission\u2014the essential roles of astrocytes. J. Neurochem. 166, 109\u2013137 (2023).","journal-title":"J. Neurochem."},{"key":"2981_CR360","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202004993","volume":"8","author":"HM Chow","year":"2021","unstructured":"Chow, H. M. et al. Low-density lipoprotein receptor-related protein 6 cell surface availability regulates fuel metabolism in astrocytes. Adv. Sci. 8, 2004993 (2021).","journal-title":"Adv. Sci."},{"key":"2981_CR361","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41586-026-10191-6","volume":"652","author":"TO Cox","year":"2026","unstructured":"Cox, T. O. et al. Intestinal interoceptive dysfunction drives age-associated cognitive decline. Nature 652, 442\u2013450 (2026).","journal-title":"Nature"},{"key":"2981_CR362","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105198","volume":"148","author":"JV Andersen","year":"2021","unstructured":"Andersen, J. V. et al. Deficient astrocyte metabolism impairs glutamine synthesis and neurotransmitter homeostasis in a mouse model of Alzheimer\u2019s disease. Neurobiol. Dis. 148, 105198 (2021).","journal-title":"Neurobiol. Dis."},{"key":"2981_CR363","doi-asserted-by":"publisher","first-page":"11677","DOI":"10.3390\/ijms222111677","volume":"22","author":"GA Czapski","year":"2021","unstructured":"Czapski, G. A. & Strosznajder, J. B. Glutamate and GABA in microglia-neuron cross-talk in Alzheimer\u2019s disease. Int. J. Mol. Sci. 22, 11677 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"2981_CR364","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/ana.26713","volume":"94","author":"HS McLoughlin","year":"2023","unstructured":"McLoughlin, H. S. et al. Antisense oligonucleotide silencing reverses abnormal neurochemistry in spinocerebellar ataxia 3 mice. Ann. Neurol. 94, 658\u2013671 (2023).","journal-title":"Ann. Neurol."},{"key":"2981_CR365","doi-asserted-by":"publisher","first-page":"e877","DOI":"10.1038\/tp.2016.140","volume":"6","author":"L Su","year":"2016","unstructured":"Su, L. et al. Whole-brain patterns of 1H-magnetic resonance spectroscopy imaging in Alzheimer\u2019s disease and dementia with Lewy bodies. Transl. Psychiatry. 6, e877\u2013e877 (2016).","journal-title":"Transl. Psychiatry."},{"key":"2981_CR366","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/1352458515586086","volume":"22","author":"EL MacMillan","year":"2015","unstructured":"MacMillan, E. L. et al. Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years. Mult. Scler. J. 22, 112\u2013116 (2015).","journal-title":"Mult. Scler. J."},{"key":"2981_CR367","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.biocel.2017.01.017","volume":"85","author":"H Tong","year":"2017","unstructured":"Tong, H. et al. Amyloid-beta peptide decreases expression and function of glutamate transporters in nervous system cells. Int. J. Biochem. Cell Biol. 85, 75\u201384 (2017).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2981_CR368","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41420-024-01827-5","volume":"10","author":"L Li","year":"2024","unstructured":"Li, L., Li, W., Jiang, W. & Xu, R. Sulbactam protects neurons against double neurotoxicity of amyloid beta and glutamate load by upregulating glial glutamate transporter 1. Cell Death Discov. 10, 64 (2024).","journal-title":"Cell Death Discov."},{"key":"2981_CR369","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.neuint.2009.12.021","volume":"56","author":"J Zou","year":"2010","unstructured":"Zou, J. et al. Glutamine synthetase down-regulation reduces astrocyte protection against glutamate excitotoxicity to neurons. Neurochem. Int. 56, 577\u2013584 (2010).","journal-title":"Neurochem. Int."},{"key":"2981_CR370","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.immuni.2025.01.007","volume":"58","author":"RM McManus","year":"2025","unstructured":"McManus, R. M. et al. NLRP3-mediated glutaminolysis controls microglial phagocytosis to promote Alzheimer\u2019s disease progression. Immunity 58, 326\u2013343.e311 (2025).","journal-title":"Immunity"},{"key":"2981_CR371","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/ana.26464","volume":"92","author":"L Sun","year":"2022","unstructured":"Sun, L. et al. Association between human blood metabolome and the risk of Alzheimer\u2019s Disease. Ann. Neurol. 92, 756\u2013767 (2022).","journal-title":"Ann. Neurol."},{"key":"2981_CR372","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.4103\/NRR.NRR-D-24-01519","volume":"21","author":"SM Bell","year":"2026","unstructured":"Bell, S. M. & Mortiboys, H. Astrocyte glycolysis in Alzheimer\u2019s disease: when the stars burn out. Neural Regener. Res. 21, 1130\u20131131 (2026).","journal-title":"Neural Regener. Res."},{"key":"2981_CR373","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1038\/jcbfm.2011.84","volume":"31","author":"MT Wyss","year":"2011","unstructured":"Wyss, M. T., Magistretti, P. J., Buck, A. & Weber, B. Labeled acetate as a marker of astrocytic metabolism. J. Cereb. Blood Flow Metab. 31, 1668\u20131674 (2011).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"2981_CR374","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-021-00842-2","volume":"14","author":"JV Andersen","year":"2021","unstructured":"Andersen, J. V. et al. Astrocyte metabolism of the medium-chain fatty acids octanoic acid and decanoic acid promotes GABA synthesis in neurons via elevated glutamine supply. Mol. Brain 14, 132 (2021).","journal-title":"Mol. Brain"},{"key":"2981_CR375","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13246","volume":"19","author":"J Doustar","year":"2020","unstructured":"Doustar, J. et al. Parallels between retinal and brain pathology and response to immunotherapy in old, late-stage Alzheimer\u2019s disease mouse models. Aging Cell 19, e13246 (2020).","journal-title":"Aging Cell"},{"key":"2981_CR376","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13195-025-01672-3","volume":"17","author":"Y Shen","year":"2025","unstructured":"Shen, Y. et al. CEST imaging combined with 1H-MRS reveal the neuroprotective effects of riluzole by improving neurotransmitter imbalances in Alzheimer\u2019s disease mice. Alzheimers Res. Ther. 17, 20 (2025).","journal-title":"Alzheimers Res. Ther."},{"key":"2981_CR377","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.3390\/ijms24032500","volume":"24","author":"A Kola","year":"2023","unstructured":"Kola, A., Lamponi, S., Curr\u00f2, F. & Valensin, D. A comparative study between lycorine and galantamine abilities to interact with AMYLOID \u03b2 and reduce in vitro neurotoxicity. Int. J. Mol. Sci. 24, 2500 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2981_CR378","doi-asserted-by":"publisher","first-page":"2467S","DOI":"10.1093\/jn\/131.9.2467S","volume":"131","author":"BI Labow","year":"2001","unstructured":"Labow, B. I., Souba, W. W. & Abcouwer, S. F. Mechanisms governing the expression of the enzymes of glutamine metabolism\u2014glutaminase and glutamine synthetase. J. Nutr. 131, 2467S\u20132474S (2001).","journal-title":"J. Nutr."},{"key":"2981_CR379","doi-asserted-by":"publisher","first-page":"104215","DOI":"10.1016\/j.redox.2026.104215","volume":"94","author":"R Wang","year":"2026","unstructured":"Wang, R. et al. The glutamate\u2013glutathione axis in neuropsychiatric disorders and cancer: from shared mechanisms to non-invasive biomarkers. Redox Biol. 94, 104215 (2026).","journal-title":"Redox Biol."},{"key":"2981_CR380","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03254-w","volume":"21","author":"Z Zhang","year":"2024","unstructured":"Zhang, Z. et al. Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer\u2019s disease. J. Neuroinflamm. 21, 261 (2024).","journal-title":"J. Neuroinflamm."},{"key":"2981_CR381","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00401-022-02528-y","volume":"145","author":"S Moonen","year":"2022","unstructured":"Moonen, S. et al. Pyroptosis in Alzheimer\u2019s disease: cell type-specific activation in microglia, astrocytes and neurons. Acta Neuropathol. 145, 175\u2013195 (2022).","journal-title":"Acta Neuropathol."},{"key":"2981_CR382","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cmet.2022.07.014","volume":"34","author":"L Traxler","year":"2022","unstructured":"Traxler, L. et al. Warburg-like metabolic transformation underlies neuronal degeneration in sporadic Alzheimer\u2019s disease. Cell Metab. 34, 1248\u20131263.e1246 (2022).","journal-title":"Cell Metab."},{"key":"2981_CR383","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306469","volume":"11","author":"AY Andreyev","year":"2024","unstructured":"Andreyev, A. Y. et al. Metabolic bypass rescues aberrant s-nitrosylation-induced TCA cycle inhibition and synapse loss in Alzheimer\u2019s disease human neurons. Adv. Sci. 11, 2306469 (2024).","journal-title":"Adv. Sci."},{"key":"2981_CR384","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.cmet.2024.02.011","volume":"36","author":"D Li","year":"2024","unstructured":"Li, D. et al. Aging-induced tRNAGlu-derived fragment impairs glutamate biosynthesis by targeting mitochondrial translation-dependent cristae organization. Cell Metab. 36, 1059\u20131075.e1059 (2024).","journal-title":"Cell Metab."},{"key":"2981_CR385","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbi.2017.06.007","volume":"66","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Glutaminase C overexpression in the brain induces learning deficits, synaptic dysfunctions, and neuroinflammation in mice. Brain. Behav. Immun. 66, 135\u2013145 (2017).","journal-title":"Brain. Behav. Immun."},{"key":"2981_CR386","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13195-022-01004-9","volume":"14","author":"PT Zebhauser","year":"2022","unstructured":"Zebhauser, P. T. et al. Cerebrospinal fluid lactate levels along the Alzheimer\u2019s disease continuum and associations with blood-brain barrier integrity, age, cognition, and biomarkers. Alzheimers Res. Ther. 14, 61 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"2981_CR387","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00401-024-02790-2","volume":"148","author":"P Botella Lucena","year":"2024","unstructured":"Botella Lucena, P. & Heneka, M. T. Inflammatory aspects of Alzheimer\u2019s disease. Acta Neuropathol. 148, 31 (2024).","journal-title":"Acta Neuropathol."},{"key":"2981_CR388","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41582-023-00822-1","volume":"19","author":"R Patani","year":"2023","unstructured":"Patani, R., Hardingham, G. E. & Liddelow, S. A. Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration. Nat. Rev. Neurol. 19, 395\u2013409 (2023).","journal-title":"Nat. Rev. Neurol."},{"key":"2981_CR389","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3233\/JAD-230199","volume":"95","author":"Y Wu","year":"2023","unstructured":"Wu, Y. & Eisel, U. L. M. Microglia-astrocyte communication in Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 95, 785\u2013803 (2023).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"2981_CR390","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s42255-023-00756-4","volume":"5","author":"Y Mi","year":"2023","unstructured":"Mi, Y. et al. Loss of fatty acid degradation by astrocytic mitochondria triggers neuroinflammation and neurodegeneration. Nat. Metab. 5, 445\u2013465 (2023).","journal-title":"Nat. Metab."},{"key":"2981_CR391","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03046-2","volume":"21","author":"T Wang","year":"2024","unstructured":"Wang, T. et al. Dimethyl fumarate improves cognitive impairment and neuroinflammation in mice with Alzheimer\u2019s disease. J. Neuroinflamm. 21, 55 (2024).","journal-title":"J. Neuroinflamm."},{"key":"2981_CR392","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02534-7","volume":"19","author":"K Freitag","year":"2022","unstructured":"Freitag, K. et al. Spermidine reduces neuroinflammation and soluble amyloid beta in an Alzheimer\u2019s disease mouse model. J. Neuroinflamm. 19, 172 (2022).","journal-title":"J. Neuroinflamm."},{"key":"2981_CR393","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s42003-024-06615-6","volume":"7","author":"Y Zhu","year":"2024","unstructured":"Zhu, Y. et al. Naringenin ameliorates amyloid-\u03b2 pathology and neuroinflammation in Alzheimer\u2019s disease. Commun. Biol. 7, 912 (2024).","journal-title":"Commun. Biol."},{"key":"2981_CR394","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41401-021-00702-8","volume":"43","author":"J-j Kou","year":"2021","unstructured":"Kou, J. -j et al. Luteolin alleviates cognitive impairment in Alzheimer\u2019s disease mouse model via inhibiting endoplasmic reticulum stress-dependent neuroinflammation. Acta Pharmacol. Sin. 43, 840\u2013849 (2021).","journal-title":"Acta Pharmacol. Sin."},{"key":"2981_CR395","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70091","volume":"30","author":"J Yang","year":"2024","unstructured":"Yang, J. et al. The gut microbiota modulates neuroinflammation in Alzheimer\u2019s disease: elucidating crucial factors and mechanistic underpinnings. CNS Neurosci. Ther. 30, e70091 (2024).","journal-title":"CNS Neurosci. Ther."},{"key":"2981_CR396","doi-asserted-by":"publisher","first-page":"II25","DOI":"10.1007\/PL00007757","volume":"247","author":"A Plaitakis","year":"2000","unstructured":"Plaitakis, A. & Shashidharan, P. Glutamate transport and metabolism in dopaminergic neurons of substantia nigra: implications for the pathogenesis of Parkinson\u2019s disease. J. Neurol. 247, II25\u2013II35 (2000).","journal-title":"J. Neurol."},{"key":"2981_CR397","doi-asserted-by":"crossref","unstructured":"Raghu, R. & Chinnathambi, S. In Int. Rev. Neurobiol. Vol. 186 (ed. Chinnathambi S.) 75\u2013106 (Academic Press, 2026).","DOI":"10.1016\/bs.irn.2026.01.001"},{"key":"2981_CR398","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.parkreldis.2022.05.007","volume":"99","author":"C Chassain","year":"2022","unstructured":"Chassain, C. et al. Glutamate cycle changes in the putamen of patients with de novo Parkinson\u2019s disease using 1H MRS. Parkinsonism Relat. Disord. 99, 65\u201372 (2022).","journal-title":"Parkinsonism Relat. Disord."},{"key":"2981_CR399","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2025.115484","volume":"483","author":"M Liu","year":"2025","unstructured":"Liu, M. et al. The alteration of glutamate involved in the brain of Parkinson\u2019s disease patients using glutamate chemical exchange saturation transfer (GluCEST). Behav. Brain Res. 483, 115484 (2025).","journal-title":"Behav. Brain Res."},{"key":"2981_CR400","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13024-021-00425-8","volume":"16","author":"Y Shao","year":"2021","unstructured":"Shao, Y. et al. Comprehensive metabolic profiling of Parkinson\u2019s disease by liquid chromatography-mass spectrometry. Mol. Neurodegener. 16, 4 (2021).","journal-title":"Mol. Neurodegener."},{"key":"2981_CR401","doi-asserted-by":"publisher","first-page":"111349","DOI":"10.1016\/j.brainresbull.2025.111349","volume":"225","author":"NH Almohmadi","year":"2025","unstructured":"Almohmadi, N. H. et al. Glutamatergic dysfunction in neurodegenerative diseases focusing on Parkinson\u2019s disease: role of glutamate modulators. Brain Res. Bull. 225, 111349 (2025).","journal-title":"Brain Res. Bull."},{"key":"2981_CR402","doi-asserted-by":"publisher","first-page":"585584","DOI":"10.3389\/fnins.2020.585584","volume":"14","author":"J Wang","year":"2020","unstructured":"Wang, J., Wang, F., Mai, D. & Qu, S. Molecular mechanisms of glutamate toxicity in Parkinson\u2019s disease. Front. Neurosci. 14, 585584 (2020).","journal-title":"Front. Neurosci."},{"key":"2981_CR403","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.nbd.2016.01.019","volume":"89","author":"J Meiser","year":"2016","unstructured":"Meiser, J. et al. Loss of DJ-1 impairs antioxidant response by altered glutamine and serine metabolism. Neurobiol. Dis. 89, 112\u2013125 (2016).","journal-title":"Neurobiol. Dis."},{"key":"2981_CR404","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1021\/acschemneuro.3c00717","volume":"14","author":"D Shukla","year":"2023","unstructured":"Shukla, D. et al. Glutathione depletion and concomitant elevation of susceptibility in patients with Parkinson\u2019s disease: state-of-the-art MR Spectroscopy And Neuropsychological Study. ACS Chem. Neurosci. 14, 4383\u20134394 (2023).","journal-title":"ACS Chem. Neurosci."},{"key":"2981_CR405","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12199-018-0757-5","volume":"24","author":"Y Zhao","year":"2019","unstructured":"Zhao, Y. et al. Glutamine protects against oxidative stress injury through inhibiting the activation of PI3K\/Akt signaling pathway in Parkinsonian cell model. Environ. Health Prev. Med. 24, 4 (2019).","journal-title":"Environ. Health Prev. Med."},{"key":"2981_CR406","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40035-024-00409-w","volume":"13","author":"N Song","year":"2024","unstructured":"Song, N. et al. Focusing on mitochondria in the brain: from biology to therapeutics. Transl. Neurodegener. 13, 23 (2024).","journal-title":"Transl. Neurodegener."},{"key":"2981_CR407","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nsmb.3194","volume":"23","author":"MD Tuttle","year":"2016","unstructured":"Tuttle, M. D. et al. Solid-state NMR structure of a pathogenic fibril of full-length human \u03b1-synuclein. Nat. Struct. Mol. Biol. 23, 409\u2013415 (2016).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2981_CR408","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.3390\/nu14235003","volume":"14","author":"D Dy\u0144ka","year":"2022","unstructured":"Dy\u0144ka, D., Kowalcze, K. & Paziewska, A. The role of ketogenic diet in the treatment of neurological diseases. Nutrients 14, 5003 (2022).","journal-title":"Nutrients"},{"key":"2981_CR409","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.molcel.2017.02.013","volume":"65","author":"S Boeynaems","year":"2017","unstructured":"Boeynaems, S. et al. Phase separation of C9orf72 dipeptide repeats perturbs stress granule dynamics. Mol. Cell 65, 1044\u20131055.e1045 (2017).","journal-title":"Mol. Cell"},{"key":"2981_CR410","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jpsychires.2016.06.017","volume":"82","author":"J Zhao","year":"2016","unstructured":"Zhao, J. et al. Prefrontal changes in the glutamate-glutamine cycle and neuronal\/glial glutamate transporters in depression with and without suicide. J. Psychiatr. Res. 82, 8\u201315 (2016).","journal-title":"J. Psychiatr. Res."},{"key":"2981_CR411","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s42003-019-0582-4","volume":"2","author":"D Yamada","year":"2019","unstructured":"Yamada, D. et al. Inhibition of the glutamine transporter SNAT1 confers neuroprotection in mice by modulating the mTOR-autophagy system. Commun. Biol. 2, 346 (2019).","journal-title":"Commun. Biol."},{"key":"2981_CR412","doi-asserted-by":"publisher","first-page":"e70029","DOI":"10.1111\/jnc.70029","volume":"169","author":"JV Andersen","year":"2025","unstructured":"Andersen, J. V. The glutamate\/GABA-glutamine cycle: insights, updates, and advances. J. Neurochem. 169, e70029 (2025).","journal-title":"J. Neurochem."},{"key":"2981_CR413","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.pharmthera.2005.11.006","volume":"110","author":"MJ Millan","year":"2006","unstructured":"Millan, M. J. Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol. Ther. 110, 135\u2013370 (2006).","journal-title":"Pharmacol. Ther."},{"key":"2981_CR414","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49336-4","volume":"15","author":"A Al-Kachak","year":"2024","unstructured":"Al-Kachak, A. et al. Histone serotonylation in dorsal raphe nucleus contributes to stress- and antidepressant-mediated gene expression and behavior. Nat. Commun. 15, 5042 (2024).","journal-title":"Nat. Commun."},{"key":"2981_CR415","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/cns.12372","volume":"21","author":"HI Woo","year":"2015","unstructured":"Woo, H. I. et al. Plasma amino acid profiling in major depressive disorder treated with selective serotonin reuptake inhibitors. CNS Neurosci. Ther. 21, 417\u2013424 (2015).","journal-title":"CNS Neurosci. Ther."},{"key":"2981_CR416","doi-asserted-by":"publisher","first-page":"965","DOI":"10.2174\/1570159X19666210611095320","volume":"20","author":"IM Badamasi","year":"2022","unstructured":"Badamasi, I. M. et al. A preliminary nuclear magnetic resonance metabolomics study identifies metabolites that could serve as diagnostic markers of major depressive disorder. Curr. Neuropharmacol. 20, 965\u2013982 (2022).","journal-title":"Curr. Neuropharmacol."},{"key":"2981_CR417","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0500-z","volume":"9","author":"G Hasler","year":"2019","unstructured":"Hasler, G. et al. Association between prefrontal glutamine levels and neuroticism determined using proton magnetic resonance spectroscopy. Transl. Psychiatry 9, 170 (2019).","journal-title":"Transl. Psychiatry"},{"key":"2981_CR418","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrn3379","volume":"14","author":"H Park","year":"2012","unstructured":"Park, H. & Poo, M.-M. Neurotrophin regulation of neural circuit development and function. Nat. Rev. Neurosci. 14, 7\u201323 (2012).","journal-title":"Nat. Rev. Neurosci."},{"key":"2981_CR419","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1038\/s41380-022-01520-y","volume":"27","author":"AN Tartt","year":"2022","unstructured":"Tartt, A. N. et al. Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications. Mol. Psychiatry 27, 2689\u20132699 (2022).","journal-title":"Mol. Psychiatry"},{"key":"2981_CR420","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165838","volume":"1866","author":"P Prasun","year":"2020","unstructured":"Prasun, P. Mitochondrial dysfunction in metabolic syndrome. Biochim. Biophys. Acta (BBA) - Mol. Basis Dis. 1866, 165838 (2020).","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"2981_CR421","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","volume":"18","author":"A Cuadrado","year":"2019","unstructured":"Cuadrado, A. et al. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat. Rev. Drug Discov. 18, 295\u2013317 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2981_CR422","doi-asserted-by":"publisher","first-page":"149572","DOI":"10.1016\/j.brainres.2025.149572","volume":"1856","author":"G Hu","year":"2025","unstructured":"Hu, G. & Cao, H. Nuclear factor erythroid 2-related factor improves depression and cognitive dysfunction in rats with ischemic stroke by mediating wolfram syndrome 1. Brain Res. 1856, 149572 (2025).","journal-title":"Brain Res."},{"key":"2981_CR423","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03312-3","volume":"22","author":"W Jiao","year":"2025","unstructured":"Jiao, W. et al. The immunological perspective of major depressive disorder: unveiling the interactions between central and peripheral immune mechanisms. J. Neuroinflamm. 22, 10 (2025).","journal-title":"J. Neuroinflamm."},{"key":"2981_CR424","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/s41401-024-01441-2","volume":"46","author":"JS Kang","year":"2025","unstructured":"Kang, J. S. et al. Activation of glutamine synthetase (GS) as a new strategy for the treatment of major depressive disorder and other GS-related diseases. Acta Pharmacol. Sin. 46, 880\u2013891 (2025).","journal-title":"Acta Pharmacol. Sin."},{"key":"2981_CR425","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/cns.13999","volume":"29","author":"B Zhang","year":"2022","unstructured":"Zhang, B. et al. Hyperbaric oxygen improves depression-like behaviors in chronic stress model mice by remodeling gut microbiota and regulating host metabolism. CNS Neurosci. Ther. 29, 239\u2013255 (2022).","journal-title":"CNS Neurosci. Ther."},{"key":"2981_CR426","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1210\/clinem\/dgac707","volume":"108","author":"R He","year":"2023","unstructured":"He, R. et al. Causal association between obesity, circulating glutamine levels, and depression: a Mendelian randomization study. J. Clin. Endocrinol. Metab. 108, 1432\u20131441 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2981_CR427","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neuropharm.2018.09.040","volume":"143","author":"H Son","year":"2018","unstructured":"Son, H. et al. Glutamine has antidepressive effects through increments of glutamate and glutamine levels and glutamatergic activity in the medial prefrontal cortex. Neuropharmacology 143, 143\u2013152 (2018).","journal-title":"Neuropharmacology"},{"key":"2981_CR428","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-02253-w","volume":"12","author":"AO Kruse","year":"2022","unstructured":"Kruse, A. O. & Bustillo, J. R. Glutamatergic dysfunction in Schizophrenia. Transl. Psychiatry. 12, 500 (2022).","journal-title":"Transl. Psychiatry."},{"key":"2981_CR429","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-07289-2","volume":"23","author":"M Liu","year":"2025","unstructured":"Liu, M. et al. Targeted metabolomics study on peripheral blood neurotransmitters in early-onset schizophrenia. J. Transl. Med. 23, 1238 (2025).","journal-title":"J. Transl. Med."},{"key":"2981_CR430","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1021\/cn5003368","volume":"6","author":"M M\u00f6ller","year":"2015","unstructured":"M\u00f6ller, M., Swanepoel, T. & Harvey, B. H. Neurodevelopmental animal models reveal the convergent role of neurotransmitter systems, inflammation, and oxidative stress as biomarkers of schizophrenia: implications for novel drug development. ACS Chem. Neurosci. 6, 987\u20131016 (2015).","journal-title":"ACS Chem. Neurosci."},{"key":"2981_CR431","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70069","volume":"30","author":"ZZ Guan","year":"2024","unstructured":"Guan, Z. Z. Alterations in neuronal nicotinic acetylcholine receptors in the pathogenesis of various cognitive impairments. CNS Neurosci. Ther. 30, e70069 (2024).","journal-title":"CNS Neurosci. Ther."},{"key":"2981_CR432","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.765809","volume":"8","author":"T Yang","year":"2021","unstructured":"Yang, T. et al. Meta-analysis of glutamine on immune function and post-operative complications of patients with colorectal cancer. Front. Nutr. 8, 765809 (2021).","journal-title":"Front. Nutr."},{"key":"2981_CR433","doi-asserted-by":"publisher","first-page":"1040893","DOI":"10.3389\/fnut.2023.1040893","volume":"10","author":"G Tang","year":"2023","unstructured":"Tang, G., Pi, F., Qiu, Y.-H. & Wei, Z.-Q. Postoperative parenteral glutamine supplementation improves the short-term outcomes in patients undergoing colorectal cancer surgery: a propensity score matching study. Front. Nutr. 10, 1040893 (2023).","journal-title":"Front. Nutr."},{"key":"2981_CR434","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.3390\/nu16142301","volume":"16","author":"J-M Wu","year":"2024","unstructured":"Wu, J.-M. et al. Perioperative glutamine supplementation may restore atrophy of psoas muscles in gastric adenocarcinoma patients undergoing gastrectomy. Nutrients 16, 2301 (2024).","journal-title":"Nutrients"},{"key":"2981_CR435","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.3390\/nu15132911","volume":"15","author":"Z Kamocki","year":"2023","unstructured":"Kamocki, Z. et al. Preoperative glutamine supplementation in gastric cancer\u2014thrombocyte phagocytic activity and early postoperative outcomes. Nutrients 15, 2911 (2023).","journal-title":"Nutrients"},{"key":"2981_CR436","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.burns.2021.12.005","volume":"48","author":"ZE Wang","year":"2022","unstructured":"Wang, Z. E. et al. Glutamine relieves the hypermetabolic response and reduces organ damage in severe burn patients: a multicenter, randomized controlled clinical trial. Burns 48, 1606\u20131617 (2022).","journal-title":"Burns"},{"key":"2981_CR437","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1056\/NEJMoa1212722","volume":"368","author":"D Heyland","year":"2013","unstructured":"Heyland, D. et al. A randomized trial of glutamine and antioxidants in critically Ill patients. N. Engl. J. Med. 368, 1489\u20131497 (2013).","journal-title":"N. Engl. J. Med."},{"key":"2981_CR438","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJMoa2203364","volume":"387","author":"DK Heyland","year":"2022","unstructured":"Heyland, D. K. et al. A randomized trial of enteral glutamine for treatment of burn injuries. N. Engl. J. Med. 387, 1001\u20131010 (2022).","journal-title":"N. Engl. J. Med."},{"key":"2981_CR439","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1097\/CCM.0000000000005887","volume":"51","author":"L Ortiz-Reyes","year":"2023","unstructured":"Ortiz-Reyes, L. et al. The efficacy of glutamine supplementation in severe adult burn patients: a systematic review with trial sequential meta-analysis. Crit. Care Med. 51, 1086\u20131095 (2023).","journal-title":"Crit. Care Med."},{"key":"2981_CR440","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1039\/C7FO00181A","volume":"8","author":"Q Chen","year":"2017","unstructured":"Chen, Q. et al. Effects of early enteral nutrition supplemented with collagen peptides on post-burn inflammatory responses in a mouse model. Food Funct. 8, 1933\u20131941 (2017).","journal-title":"Food Funct."},{"key":"2981_CR441","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.clnu.2014.05.006","volume":"34","author":"IM Grintescu","year":"2015","unstructured":"Grintescu, I. M. et al. The influence of parenteral glutamine supplementation on glucose homeostasis in critically ill polytrauma patients\u2014a randomized-controlled clinical study. Clin. Nutr. 34, 377\u2013382 (2015).","journal-title":"Clin. Nutr."},{"key":"2981_CR442","doi-asserted-by":"publisher","first-page":"e353","DOI":"10.1097\/CCM.0000000000001640","volume":"44","author":"KWY van Barneveld","year":"2016","unstructured":"van Barneveld, K. W. Y. et al. Beneficial effects of early enteral nutrition after major rectal surgery: a possible role for conditionally essential amino acids? Results of a randomized clinical trial. Crit. Care Med. 44, e353\u2013e361 (2016).","journal-title":"Crit. Care Med."},{"key":"2981_CR443","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3390\/nu10070820","volume":"10","author":"L Burgess","year":"2018","unstructured":"Burgess, L., Phillips, S. & Wainwright, T. What is the role of nutritional supplements in support of total hip replacement and total knee replacement surgeries? A systematic review. Nutrients 10, 820 (2018).","journal-title":"Nutrients"},{"key":"2981_CR444","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3390\/nu13030899","volume":"13","author":"H Nakano","year":"2021","unstructured":"Nakano, H. et al. Urinary titin N-fragment evaluation in a randomized controlled trial of beta-hydroxy-beta-methylbutyrate for acute mild trauma in older adults. Nutrients 13, 899 (2021).","journal-title":"Nutrients"},{"key":"2981_CR445","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.clnu.2023.11.011","volume":"43","author":"B Liang","year":"2024","unstructured":"Liang, B. et al. Glutamine enteral therapy for critically ill adult patients: an updated meta-analysis of randomized controlled trials and trial sequential analysis. Clin. Nutr. 43, 124\u2013133 (2024).","journal-title":"Clin. Nutr."},{"key":"2981_CR446","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1097\/CCM.0000000000005499","volume":"50","author":"RW Haines","year":"2022","unstructured":"Haines, R. W. et al. Catabolism in critical illness: a reanalysis of the reducing deaths due to OXidative Stress (REDOXS) Trial*. Crit. Care Med. 50, 1072\u20131082 (2022).","journal-title":"Crit. Care Med."},{"key":"2981_CR447","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.clnu.2015.01.019","volume":"35","author":"I Jordan","year":"2016","unstructured":"Jordan, I. et al. Glutamine effects on heat shock protein 70 and interleukines 6 and 10: Randomized trial of glutamine supplementation versus standard parenteral nutrition in critically ill children. Clin. Nutr. 35, 34\u201340 (2016).","journal-title":"Clin. Nutr."},{"key":"2981_CR448","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1016\/j.clnu.2024.09.025","volume":"43","author":"K Wittholz","year":"2024","unstructured":"Wittholz, K. et al. A systematic review to assess the impact of amino acids or their derivatives on skeletal muscle wasting in critically ill patients. Clin. Nutr. 43, 2458\u20132472 (2024).","journal-title":"Clin. Nutr."},{"key":"2981_CR449","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/nu16020222","volume":"16","author":"C Wunderle","year":"2024","unstructured":"Wunderle, C. et al. Association of glutamine and glutamate metabolism with mortality among patients at nutritional risk\u2014a secondary analysis of the randomized clinical trial EFFORT. Nutrients 16, 222 (2024).","journal-title":"Nutrients"},{"key":"2981_CR450","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.phrs.2017.12.007","volume":"130","author":"J Gunst","year":"2018","unstructured":"Gunst, J., Vanhorebeek, I., Thiessen, S. E. & Van den Berghe, G. Amino acid supplements in critically ill patients. Pharmacol. Res. 130, 127\u2013131 (2018).","journal-title":"Pharmacol. Res."},{"key":"2981_CR451","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ccc.2017.08.008","volume":"34","author":"PE Wischmeyer","year":"2018","unstructured":"Wischmeyer, P. E. Nutrition therapy in sepsis. Crit. Care Clin. 34, 107\u2013125 (2018).","journal-title":"Crit. Care Clin."},{"key":"2981_CR452","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1038\/onc.2015.447","volume":"35","author":"L Jin","year":"2015","unstructured":"Jin, L., Alesi, G. N. & Kang, S. Glutaminolysis as a target for cancer therapy. Oncogene 35, 3619\u20133625 (2015).","journal-title":"Oncogene"},{"key":"2981_CR453","doi-asserted-by":"publisher","first-page":"189335","DOI":"10.1016\/j.bbcan.2025.189335","volume":"1880","author":"Y-j Hou","year":"2025","unstructured":"Hou, Y. -j, Yang, X. -x & Meng, H.-X. Mitochondrial metabolism in laryngeal cancer: therapeutic mechanisms and prospects. Biochim. Biophys. Acta (BBA) - Rev. Cancer 1880, 189335 (2025).","journal-title":"Biochim. Biophys. Acta (BBA) - Rev. Cancer"},{"key":"2981_CR454","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.3390\/nu12061675","volume":"12","author":"PM Anderson","year":"2020","unstructured":"Anderson, P. M. & Lalla, R. V. Glutamine for amelioration of radiation and chemotherapy associated mucositis during cancer therapy. Nutrients 12, 1675 (2020).","journal-title":"Nutrients"},{"key":"2981_CR455","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.3390\/nu15194117","volume":"15","author":"T Tsujimoto","year":"2023","unstructured":"Tsujimoto, T., Wasa, M., Inohara, H. & Ito, T. L-Glutamine and survival of patients with locally advanced head and neck cancer receiving chemoradiotherapy. Nutrients 15, 4117 (2023).","journal-title":"Nutrients"},{"key":"2981_CR456","doi-asserted-by":"publisher","first-page":"821924","DOI":"10.3389\/fnut.2022.821924","volume":"9","author":"SE Tan","year":"2022","unstructured":"Tan, S. E., Abdul Satar, N. F. & Majid, H. A. Effects of immunonutrition in head and neck cancer patients undergoing cancer treatment \u2013 a systematic review. Front. Nutr. 9, 821924 (2022).","journal-title":"Front. Nutr."},{"key":"2981_CR457","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.clnu.2016.06.012","volume":"36","author":"K Gul","year":"2017","unstructured":"Gul, K., Mehmet, K. & Meryem, A. The effects of oral glutamine on clinical and survival outcomes of non-small cell lung cancer patients treated with chemoradiotherapy. Clin. Nutr. 36, 1022\u20131028 (2017).","journal-title":"Clin. Nutr."},{"key":"2981_CR458","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17181-w","volume":"11","author":"MB Ishak Gabra","year":"2020","unstructured":"Ishak Gabra, M. B. et al. Dietary glutamine supplementation suppresses epigenetically-activated oncogenic pathways to inhibit melanoma tumour growth. Nat. Commun. 11, 3326 (2020).","journal-title":"Nat. Commun."},{"key":"2981_CR459","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/SLA.0000000000006116","volume":"279","author":"R Matsui","year":"2024","unstructured":"Matsui, R. et al. Impact of perioperative immunonutrition on postoperative outcomes for patients undergoing head and neck or gastrointestinal cancer surgeries. Ann. Surg. 279, 419\u2013428 (2024).","journal-title":"Ann. Surg."},{"key":"2981_CR460","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.3390\/nu15122772","volume":"15","author":"J Ye","year":"2023","unstructured":"Ye, J. et al. Comparative effects of different nutritional supplements on inflammation, nutritional status, and clinical outcomes in colorectal cancer patients: a systematic review and network meta-analysis. Nutrients 15, 2772 (2023).","journal-title":"Nutrients"},{"key":"2981_CR461","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.clnu.2020.06.015","volume":"40","author":"J-M Wu","year":"2021","unstructured":"Wu, J.-M. et al. Parenteral glutamine supplementation improves serum albumin values in surgical cancer patients. Clin. Nutr. 40, 645\u2013650 (2021).","journal-title":"Clin. Nutr."},{"key":"2981_CR462","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1002\/jcsm.12817","volume":"12","author":"S Catanese","year":"2021","unstructured":"Catanese, S. et al. Biomarkers related to fatty acid oxidative capacity are predictive for continued weight loss in cachectic cancer patients. J. Cachexia Sarcopenia Muscle. 12, 2101\u20132110 (2021).","journal-title":"J. Cachexia Sarcopenia Muscle."},{"key":"2981_CR463","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2026.1735401","volume":"16","author":"H Lu","year":"2026","unstructured":"Lu, H. et al. Glutamine alleviates radiation-induced intestinal injury in rats via the mTOR\/Notch1 axis. Front. Oncol. 16, 1735401 (2026).","journal-title":"Front. Oncol."},{"key":"2981_CR464","doi-asserted-by":"publisher","first-page":"1418738","DOI":"10.3389\/fimmu.2024.1418738","volume":"15","author":"N Li","year":"2024","unstructured":"Li, N. et al. Exploring the causal relationship between glutamine metabolism and leukemia risk: a Mendelian randomization and LC-MS\/MS analysis. Front. Immunol. 15, 1418738 (2024).","journal-title":"Front. Immunol."},{"key":"2981_CR465","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.1039\/C9TB01225G","volume":"7","author":"P Zhou","year":"2019","unstructured":"Zhou, P. et al. Glutamine-\u03b2-cyclodextrin for targeted doxorubicin delivery to triple-negative breast cancer tumors via the transporter ASCT2. J. Mater. Chem. B 7, 5363\u20135375 (2019).","journal-title":"J. Mater. Chem. B"},{"key":"2981_CR466","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.trecan.2017.01.005","volume":"3","author":"AA Cluntun","year":"2017","unstructured":"Cluntun, A. A., Lukey, M. J., Cerione, R. A. & Locasale, J. W. Glutamine metabolism in cancer: understanding the heterogeneity. Trends Cancer 3, 169\u2013180 (2017).","journal-title":"Trends Cancer"},{"key":"2981_CR467","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.trecan.2024.11.008","volume":"11","author":"SF Grenier","year":"2025","unstructured":"Grenier, S. F. & Commisso, C. A hormetic response model for glutamine stress in cancer. Trends Cancer 11, 196\u2013203 (2025).","journal-title":"Trends Cancer"},{"key":"2981_CR468","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.117217","volume":"242","author":"D Qu","year":"2025","unstructured":"Qu, D. et al. Reprogramming the impact of glutamine metabolism on controlling the immunoinflammatory milieu in psoriasis. Biochem. Pharmacol. 242, 117217 (2025).","journal-title":"Biochem. Pharmacol."},{"key":"2981_CR469","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1021\/acs.jmedchem.8b00961","volume":"62","author":"X Xu","year":"2019","unstructured":"Xu, X. et al. Overview of the development of glutaminase inhibitors: achievements and future directions. J. Med. Chem. 62, 1096\u20131115 (2019).","journal-title":"J. Med. Chem."},{"key":"2981_CR470","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/pharmaceutics15020437","volume":"15","author":"K Sagini","year":"2023","unstructured":"Sagini, K. et al. Lipid biomarkers in liquid biopsies: novel opportunities for cancer diagnosis. Pharmaceutics 15, 437 (2023).","journal-title":"Pharmaceutics"},{"key":"2981_CR471","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40364-026-00902-6","volume":"14","author":"Y Chen","year":"2026","unstructured":"Chen, Y. et al. Mitochondrial DNA mutations and intercellular mitochondrial transfer in cancer: mechanisms, biological effects, and clinical potential. Biomarker. Res. 14, 29 (2026).","journal-title":"Biomarker. Res."},{"key":"2981_CR472","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2967\/jnumed.116.182345","volume":"58","author":"L Zhu","year":"2017","unstructured":"Zhu, L. et al. Metabolic imaging of glutamine in cancer. J. Nucl. Med. 58, 533\u2013537 (2017).","journal-title":"J. Nucl. Med."},{"key":"2981_CR473","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cytogfr.2023.08.003","volume":"73","author":"F Anastasi","year":"2023","unstructured":"Anastasi, F. et al. Proteomics analysis of circulating small extracellular vesicles: focus on the contribution of EVs to tumor metabolism. Cytokine Growth Factor Rev. 73, 3\u201319 (2023).","journal-title":"Cytokine Growth Factor Rev."},{"key":"2981_CR474","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41420-025-02767-4","volume":"11","author":"H Lv","year":"2025","unstructured":"Lv, H. et al. Glutamine: a new strategy for targeted metabolic therapy in the tumor microenvironment. Cell Death Discov. 11, 459 (2025).","journal-title":"Cell Death Discov."},{"key":"2981_CR475","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03775-4","volume":"22","author":"T Duraj","year":"2024","unstructured":"Duraj, T. et al. Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma. BMC Med. 22, 578 (2024).","journal-title":"BMC Med."},{"key":"2981_CR476","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189257","volume":"1880","author":"C Dong","year":"2025","unstructured":"Dong, C. et al. Targeting glutamine metabolism crosstalk with tumor immune response. Biochim. Biophys. Acta (BBA) - Rev. Cancer. 1880, 189257 (2025).","journal-title":"Biochim. Biophys. Acta (BBA) - Rev. Cancer."},{"key":"2981_CR477","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2025.101834","volume":"13","author":"Z Li","year":"2026","unstructured":"Li, Z. et al. Overview of glutamine metabolism in stromal components of the tumor microenvironment and potential anti-tumor therapies. Genes Dis. 13, 101834 (2026).","journal-title":"Genes Dis."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02981-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02981-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02981-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:02:59Z","timestamp":1791241379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02981-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":477,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2981"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02981-1","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"425"}}